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Abstract 
Affective dysfunction including anxiety disorders are a major consequence of traumatic brain 
injury (TBI). However, much remains to be understood about the underlying neural signaling 
mechanisms. A lack of consensus in animal studies regarding the affective sequelae of TBI has 
been a major hurdle that has slowed progress, with studies reporting increase, decrease, as well 
as no change in anxiety following injury. Here, we addressed this issue directly in two series of 
experiments in mice following moderate to severe controlled cortical impact (CCI) injury. In the 
first, we examined the impact of injury on anxiety outcomes with a battery of  different 
behavioral assays of anxiety as well as multiple time points (over 2 months post-injury), 
adopting the traditional approach of comparing the injured group with sham controls.  Results 
from our experiments showed that the effect of injury is both time- and task-dependent, 
highlighting the importance of a multidimensional approach to studying anxiety following injury. 
In the second, we examined the role of individual variability in the response to injury. 
Specifically, we hypothesized (a) that there is substantial variability in the responses of 
individuals to TBI leading to a range of anxiety levels post-TBI, and (b) that comparison 
between extreme responders to TBI (rather than between TBI and sham controls) would lead to 
key insights into neural mechanisms of anxiety following injury. To test these hypotheses, we 
developed a novel approach that reliably identified animals either vulnerable or resilient to injury 
using the multidimensional behavioral profiles measured for each animal over time. This 
approach employed a combination of principal components analysis (PCA), unsupervised 
clustering, and behavioral validation to reliably identify animals either vulnerable or resilient to 
TBI. Immunostaining experiments in key areas of the corticolimbic network revealed robust 
multi-molecular signatures (of GABA, VGLUT and NPY expression) of vulnerability to anxiety 
ii
following injury. Notably, the extent of vulnerability to anxiety was tightly correlated with the 
changes in molecular expression across vulnerable individuals. Taken together, this work 
proposes a novel, multidimensional approach to the study of anxiety outcomes following injury, 
that has the power to uncover reliable neural mechanisms underlying vulnerability to anxiety. 
Keywords: traumatic brain injury, anxiety behaviors, controlled cortical impact, resilience, 
vulnerability. 
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Chapter 1: Anxiety outcomes in animal models of traumatic brain injury 
1. Introduction 
 Traumatic brain injury (TBI) is a significant health problem, which presents a high 
prevalence worldwide [1, 2] and causes severe physical, social, and economic impairments [3]. 
Patients who suffer from even a mild or moderate TBI, which corresponds to approximately 80% 
of all injuries, are at a higher risk than the non-TBI population of developing cognitive [4], motor 
[5], and psychiatric disorders [6]. In particular, anxiety-related disorders, such as generalized 
anxiety disorder and post-traumatic stress disorder, affect up to 70% of all TBI patients [7]. 
Therefore, it is imperative to understand the underlying neural mechanisms of injury linked to 
anxiety disorders to manage adverse outcomes and improve patients’ quality of life. 
 Animal models of injury have been widely used, in particular, rodent models, to replicate 
human symptomatology, understand the neural mechanisms of injury, and develop better 
therapeutic interventions for TBI patients. Overall, studies aiming at anxiety outcomes of TBI in 
rodent models measure unconditioned anxiety in exploration-based tasks [8]. Experimental 
paradigms such as the elevated plus maze (EPM), elevated zero maze (EZM), light-dark box 
(LDB) and open field test (OFT), rely on the animals’ natural, opposing tendencies to explore a 
novel environment, as well as that of seeking a safe, protected area. Anxiety-like behaviors, in 
these assays, are measured as the proportion of time an animal spends exploring an exposed, 
potentially dangerous, zone versus a more protected, safe, zone in the behavioral apparatus. 
Despite the high prevalence of anxiety disorders following TBI, animal models have not 
consistently reproduced its maladaptive affective outcomes, particularly regarding anxiety. 
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Studies measuring anxiety outcomes of TBI using these paradigms often find opposing, 
contradictory findings: some suggest that injury decreases anxiety-like behaviors, whereas others 
indicate an increase or no change in anxiety [9-14]. 
 The wide range of anxiety outcomes in animal models of TBI suggest a complex scenario 
and imply that many factors influence our interpretation of the behavioral outcomes. A diversity 
of injury models and degrees of severity, behavioral assays, and time-points have been adopted 
in these studies, which may lead to different anxiety outcomes. In this chapter, we aim to 
compare studies that have measured anxiety-like behaviors following TBI in rodents and identify 
similar or contrasting effects across behavioral assays, time-points, injury models, and severity. 
This approach will help us to define consistent methods and identify alternative approaches to 
the study of anxiety outcomes following TBI, and serves as a basis to the following chapters. In 
chapter three, we will test how different behavioral assays and time-points affect the behavioral 
outcome of TBI and anxiety. In chapter four, we will show how vulnerability and resilience may 
play a crucial role in interpreting the anxiety outcomes of TBI. Combined, these studies will shed 
new light in the anxiety outcomes of TBI in animal models, highlighting the importance of 
adopting a battery of behavioral assays and taking individual variability into account.    
2. Animal models of TBI 
 TBI is a complex neuropathology, defined by damage to the brain caused by external 
forces, such as rapid deceleration, explosions, and inertial or rotational impact [15, 16]. Primary 
and secondary injury processes combined are responsible for the degree of injury and subsequent 
outcome [17, 18]. Primary injury occurs at the moment of impact to the head and leads to tissue 
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damage, impaired regulation of cerebral blood flow, an increase in intracranial pressure, and 
metabolic dysfunction [17, 19]. The secondary injury is characterized by increased glutamate 
excitotoxicity, delayed axonal injury, inflammation due to cytokine and chemokine release, 
increase in reactive oxygen species and programmed cell death, such as apoptosis [18, 20].  
 One of the challenges in studying TBI is its complex symptomatology and variability in 
outcomes among patients. Thus, reliably reproducing the injury in an animal model is a crucial 
step. Because of its substantial heterogeneity, replicating all aspects of injury in a controlled and 
reproducible manner can be challenging. Several animal models of TBI have been developed 
over the past few decades, to try to replicate specific aspects of the injury, and they have been 
useful in understanding several neural markers of TBI. Here, we will briefly review the most 
commonly used TBI models in rodents and how differences in injury model and severity can 
confound anxiety outcomes following brain injury. 
2.1 Weight-drop injury (WDI) 
 WDI produces a focal brain injury with a free-falling, guided weight hitting either the intact 
skull, in the closed-head Marmarou’s, and Shohami’s models [21, 22] or the exposed intact dura 
mater, in the open-head Feeney’s model [23, 24]. The severity of the injury is controlled by 
adjusting the mass and height the weight falls. Open-head weight-drop pathologies include 
hemorrhage and necrotic cavity beneath the impact site [24]. Closed-head height drop injury 
causes loss in cell number of cortex and hippocampus [25], breakdown of the blood-brain barrier 
[16], and apoptotic cells both in the ipsi and contralateral sides of the brain [26, 27]. Weight drop 
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injuries, both in closed and open-head models, also cause motor, cognitive, and emotional 
deficits [28-31]. 
2.2 Fluid percussion injury (FPI) 
 FPI is induced by a piston rapidly hitting a reservoir of liquid, which generates a fluid 
pressure pulse that strikes the intact dura-mater, leading to a diffuse injury [32]. The severity of 
the damage is controlled by changing the height the piston is released into the fluid reservoir 
[33]. The craniotomy and subsequent injury can be made at the midline, for a central injury, or 
laterally above the parietal cortex [33, 34]. FPI causes a high degree of axonal injury, focal 
cortical lesion and hemorrhage under the injury site, and widespread cortical and subcortical 
damage [35], besides glial cell increase in the injury site [32]. FPI causes motor, cognitive, 
sensory, and affective deficits [36, 37].  
2.3 Blast-related TBI (bTBI) 
 In bTBI, a shock wave is directed to the head, to simulate an explosion, and resemble the 
common injury type in modern warfare [16, 38]. bTBI is traditionally divided into four stages 
The primary injury refers to the effect of the shockwave, the secondary injury is caused by debris 
projected at high speed, the tertiary injury involves to the blast wind that causes displacement of 
the body, and the quaternary injury is produced by the heat and smoke that follows the explosion 
[.39]. The pathologies of blast injury include contusion, edema, hemorrhage, diffuse axonal 
injury, and neurodegenerative processes across the whole brain [40]. One challenge with this 
type of injury is the considerable variation in parameters, such as head position and distance to 
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the shock wave, that can directly affect the molecular, functional, and behavioral outcomes of 
injury. Blast injury causes motor, cognitive, and behavioral deficits that can be long-lasting 
[41-43]. 
2.4 Controlled Cortical Impact (CCI)  
 CCI is generated by an electromagnetic piston directed onto the dura mater [44]. The 
degree of injury is controlled by changing the velocity, depth, and dwell time, tuning injury 
severity from mild to severe. CCI reproduces several pathological markers of human TBI [45]. 
Even though it was initially developed as a focal injury [46], studies have consistently found it 
induces diffuse axonal damage to distal brain areas affected in human TBI, such as cortex, 
hippocampus, and thalamus [47]. CCI also induces the upregulation of microglia [48], apoptotic 
cells [49], and impaired cerebral blood flow [50]. Besides pathological changes, CCI produces 
cognitive, motor, and emotional symptoms, similar to those observed in human TBI [49, 51, 52]. 
 All the injury models described here reproduce important, but often different aspects of 
clinical TBI. For instance, bTBI closely reproduces the biomechanics of injury often experience 
by military personal, while FPI produces a diffuse injury commonly experience during falls or 
car accidents. Despite being a focal injury, CCI produces both the biomechanical and 
pathological aspects of clinical TBI [16]. Besides, injury parameters are easily adjustable and 
injury is highly reproducible, with relatively low mortality rates [53]. Because of these factors, in 
the studies described in this thesis, we adopted CCI as the model to understand the anxiety 
sequelae of brain injury.  
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3. Severity of injury across TBI models and the impact on affective behavioral outcome 
 In clinical TBI, the severity of the injury is assessed by the degree of consciousness and 
structural damage to the brain [54]. A widely used method to determine consciousness is the 
Glasgow Coma Scale (GCS), or its improved version, the GCSE [55], a 15-points neurological 
scale that measures eye, verbal, and motor movements. A high score (13-15) indicates a mild 
injury, a score between 9 and 12 indicates a moderate injury, whereas a low score (8 or less) 
indicates a severe TBI [56].  
 In animal models, the severity of the injury is controlled by changing mechanical 
parameters on the injury device, which affect the degree of focal, diffuse, and mixed damage 
[16]. The degree of injury can be assessed by measuring neurological changes (i.e., righting 
reflex), physiological changes (i.e., weight loss), histological change (i.e., volumetric loss), or 
behavioral change (i.e., neurological severity score - NSS). Animal models of TBI divide the 
injury severity into mild, moderate, and severe [16]. However, there is no golden standard to 
determine injury severity that is applicable to all models [54]. One difficulty is the fact that, in 
humans, severity is determined by the level of consciousness immediately after the injury, but in 
animal models, due to anesthesia, this assessment is not always possible. Besides, in clinical 
TBI, the patients’ verbal response is a metric of consciousness. Finally, many animal studies do 
not mention the severity of the injury, which complicates interpretations and make the translation 
to clinical TBI difficult. In this section, we will describe how the parameters change in each type 
of injury, depending on the animal model used. It is worth noting, however, that in general, there 
is no standard to determine injury severity, and different research groups tend to use different 
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parameters to generate mild, moderate, and severe injury, even when using the same animal and 
injury model. 
 For the CCI model, the severity of the injury depends on the depth and velocity the piston 
hits the dura-mater. For instance, Washington et al. (2012) produced CCI in C57 mice with 
different injury levels. Velocity and dwell time were constant at 5.25 m/sec and 100 ms, 
respectively. Severity was controlled by changing the depth the piston hit the dura-mater: 1.5 mm 
(mild), 2.0 mm (moderate), and 2.5 mm (severe). Tucker et al. (2017) also produced different 
levels of CCI in C57 mice. Velocity was constant at 5.0 m/s, which is similar to Washington and 
colleagues, but the depth for their mild and severe injury was 1.0 mm and 2.0 mm, respectively, 
which is smaller than what Washington and colleagues used to generate what they considered to 
be the same level of injury. For rats, Almeida-Suhett et al. (2014) generated a mild injury in 
Sprague–Dawley rats, using the parameters: velocity 3.5 m/sec, dwell time of 200 ms, and depth 
of 2.0 mm. Wagner et al. (2007) also produced CCI in Sprague-Dawley rats. They do not qualify 
the severity of their injury, but adopted a faster and deeper injury, compared to Almeida-Suhett 
and colleagues. Their injury was at a velocity of 4.0 m/s and depth of 2.7 or 2.9 mm, which could 
be classified, in comparison to Almeida-Suhett and colleagues, as a more severe injury. 
 Siebold and colleagues (2018) reviewed studies on CCI severity and presented some 
guidelines to determine CCI severity based on tissue loss, neurological severity score, and 
cognitive deficits. In this system, a mild injury should present no or minimal loss or deficit, and 
severe injury should present the most substantial loss and deficit [53]. They also recommend the 
surgical parameters to generate each type of injury: mild injury should have a depth <0.5 mm 
and velocity <4.0 m/s, mild injury should have depth between 1.0 mm and 1.5 mm and velocity 
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between 4.0 m/s and 5 m/s, and severe injury should have depth >2.0 mm and velocity >5 m/s 
[53]. In chapters three and four, we adopt a moderate injury level, according to these parameters. 
 In the weight-drop injury models, severity is manipulated by changing the gravitational 
force, the mass, and height the weight falls. For instance, Meyer et al. (2012) induced what they 
called a mild injury in Sprague–Dawley rats by dropping a 175 g weight from 42 cm height. 
Hsieh et al. (2017) generated different levels of injury by changing the height of a 450 g weight: 
1.0 m, 1.5 m and 2.0 m for mild, moderate, and severe injury, respectively. Pandey et al. (2009) 
generated a closed-head injury in Wistar rats by dropping a cylindrical metallic weight of 400 g 
from 1 meter height. They did not qualify the severity of their injury; however, comparing it to 
the other studies, their injury can be classified as severe. In Swiss mice, Schwarzbold et al. 
(2010) generated mild, moderate, and severe injury by changing the weights used (10 g, 12.5 g, 
and 15 g, respectively), and keeping the height constant at 120 cm, but another study also in mice 
Tweedie et al. (2007) produced a mild injury in ICR mice using weights of 30 g or 50 g dropped 
from an 80 cm of height.  
 In the lateral fluid percussion injury model, severity is determined based on mortality rate 
in the first 24 h, and severity can be manipulated by changing the atmospheric pressure, 
according to a protocol by Kabadi et al. (2010,[57]). For example, Johnstone et al. (2015) 
produced a moderate injury in male Sprague-Dawley rats using a mean pulse of 3.06 atm; Jones 
et al. (2008) produced a severe injury in Wistar rats by adopting a pressure of 3.2 to 3.5 atm, and 
Shultz et al. (2011) produced a mild injury in Long-Evans rats by adopting a mean injury force 
of 1.2 atm [58]. Shultz and colleagues reported no mortality among injured animals; however, 
the other studies do not mention the mortality rate. 
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 These differences in injury parameters make it challenging to compare behavioral 
outcomes among studies. In addition, differences in time-points, the strain of animals and 
behavioral assays adopted differ across studies. Thus, a contradictory and confusing picture 
emerges as we try to characterize the affective behavioral outcomes of TBI.  
 Almeida-Suhett et al. (2014), Ajao, et al. (2012) and Wager et al. (2007) all produced mild 
CCI in rats and found increased anxiety-like behaviors. However, Amoros-Aguilar (2015) 
produced a mild CCI in rats and found no effects on anxiety-like behaviors.  In rats, however, 
Amorós-Aguilar et al. (2015) and Cutler, et al. (2006)  found reduced anxiety-like behaviors 
following a mild CCI-like injury. Cutler and colleagues, however, treated animals with 
progesterone, and they conclude that the effect on anxiety was due to this treatment. Thau-
Zuchman et al. (2018) produced a moderate CCI in mice and found increased anxiety-like 
behaviors, measured by decreased time in the open arm in the EZM, whereas Wakade et al. 
(2010) found increased ambulation in the OFT, measured by increase number of squares crosses,  
with no effect on anxiety-like behavior. Washigton et al. (2012) exposed mice to mild, moderate, 
and severe CCI and found decreased anxiety responses for all injury levels, but Tucker et al. 
(2017) exposed mice to mild or severe CCI and found increased anxiety responses on the OFT 
only for the severe injury group. However, they found decreased anxiety in the EZM, LDB, and 
marble-burying suggesting a task-dependent effect. To complicate matters further, Sierra-
Mercado et al. (2015) produced a severe CCI in mice and found no effects on anxiety-like 
behaviors in the EPM, measured by time spent in the open arm, one week post-injury. 
 Other injury models show similar contradictory findings. Meyer et al. (2012) produced a 
mild weight-drop injury in rats and found increased anxiety-like behaviors in the EPM. However, 
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Pandey et al. (2009), who also produced a mild weight-drop injury in rats, found decreased 
anxiety-like behaviors in the OFT. Schwarzbold et al. (2010) characterized varying severity 
levels (mild, moderate, and severe) of weight-drop injury in mice. They found an increase in 
ambulation on the OFT, but increased anxiety in the EPM post-severe TBI, demonstrating that 
the effect of injury on anxiety-like behaviors significantly depend on injury severity. 
 The studies described above show that even for the similar level of damage and animal and 
injury models, anxiety outcomes are varied. However, this does not take into account the time-
points tested. Studies adopt time-points as early as a few minutes post-injury [59] and as long as 
a year [60]. This broad range of time-points allows us to understand the short and long-term 
effects of TBI on anxiety, yet we lack the knowledge of what constitutes an early versus a late 
effect. A systematic study testing at which time-points the effect become long-term would shed 
light on this issue, and allow future studies to determine the adequate time-point to be tested. 
4. Assays of anxiety used in TBI studies: time course of behavioral changes 
 Several behavioral assays have been used to measure anxiety-like behaviors following TBI. 
Specifically, tests that measure innate, unconditioned anxiety have been primarily adopted. 
Those assays, often called exploration-based tasks, rely on the animals’ innate tendency to avoid 
open and bright spaces (the anxiogenic zones) and prefer closed, darker areas (anxiolytic zones). 
Anxiety, in those tests, is inferred by measuring how much the animal is willing to explore the 
different areas of the maze: more time spent in the exposed zone indicates low anxiety, whereas 
more time in the safe zone implies high anxiety [61, 62]. These behavioral assays provide 
straight-forward, quantifiable approaches to measure how exposure to the injury changes the 
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affective, anxiety-like behavior of animals following TBI. Furthermore, they serve as a substrate 
to measure molecular and functional changes that may underlie the behavioral changes. In the 
next section, we will compare the results across different behavioral tasks measuring anxiety-like 
behavior in animal models of injury, then discuss differences in injury models and injury 
severity. 
4.1 Elevated Plus Maze 
 The elevated plus maze is one of the earliest behavioral assays to assess anxiety. It is 
formed by two intersecting, narrow runways, forming a plus shape, placed at a distance from the 
ground. Two of the opposing runways have high walls, called closed arms, whereas the other two 
runways have no walls, and are called open arms [63, 64]. Anxiety is estimated by the 
exploration of the open versus closed arms. 
 The effects of TBI in the EPM are quite variable. Some studies report an increase in 
anxiety in the EPM post-TBI, measured by a decreased exploration of the open arms, or reduced 
number of entrances to the open arm. Adult and immature rats, and mice exposed to a mild 
closed head weight drop injury presented increased anxiety in the EPM on day six [65, 66], 
eleven [67] day 22 [68] and day 30 [69] post-injury. Immature rats exposed to the same type of 
injury present increased anxiety in the EPM at day six [70]. Mice exposed to a repeated weight-
drop injury presented increased anxiety on day 4 [71] and at one and two months post-injury [31] 
and mice exposed to CCI presented increased anxiety in the EPM 24h, 48h [72]. Rats exposed to 
LFP exhibited a decreased number of entrances and time in open arm in EPM between one and 
four months after injury [13, 73, 74] and increased anxiety after five repeated injuries 24h and 
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eight weeks post-injury [75]. Rats with an omega-3 deficiency presented increased anxiety seven 
days after an LFP [76], and rats exposed to an overpressure blast injury showed increased 
anxiety on day three [77, 78], nine [79], up to week 24 post-injury [80], measured by a decrease 
number of entrances and time in the open arm.  
 A few other studies, however, have reported a decrease in anxiety-like behaviors in the 
EPM, by observing a reduction in the exploration of the open arm, or increased time spent in the 
closed arm. Mice exposed to mild to severe CCI presented decreased anxiety 21 days post-injury 
[10] and mice exposed to stress paradigm plus CCI to model PTSD symptoms also presented a 
decrease in anxiety 25 days post-injury [81]. However, in this case, the effects of stress exposure 
may overlap with injury outcomes. Mice and rats exposed to a mild CCI or mild to severe 
weight-drop injury displayed an increased number of open arm entries and an increase in time 
spent in the open arm, 11 days, and nine weeks after the injury [82-84]. Siopi and colleagues 
exposed mice to a closed head weight drop and treated animals with minocycline, an antibiotic 
drug, a month after the injury. They found a small decrease in anxiety on the EPM three to seven 
weeks preceding treatment, measured by a slight increase in head dips [85].  In another study 
testing the effect of drug treatment, rats exposed to a cortical contusion injury and treated with 
progesterone up to six days later presented decreased anxiety, measured by increased time in the 
open arm [86].  
 Interestingly, several studies found no effect of injury on the EPM. Mice and rats exposed 
to CCI exhibited no change in anxiety-like behaviors in the EPM on one week, 28 days, and 
three to six weeks post-injury [87-89]. Juvenile rats exposed to a repeated weight drop injury 
were not different from controls three months post-injury [90]. Similarly, mice and rats exposed 
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to a single or repeated weight-drop injury presented no change in the EPM ten days to a year 
after injury [60, 91-95], and mice and rats exposed to single or repeated LFP presented no 
behavioral change in the EPM from one to twelve weeks after injury [75, 96-98]. 
 Finally, Petraglia and colleagues found opposing effects on anxiety in the EPM, depending 
on the time-point measured. They exposed mice to a single or repeated closed-head weight-drop 
injury and found increased anxiety on day 14 for both single and repeated injury, but anxiety 
decreased one to six months later for animals exposed to repeated injury [99]. 
4.2 Elevated Zero Maze 
 The EZM is a circular version of the EPM, with two open and two closed quadrants, in 
which there is no ambiguous center zone as in the EPM [100, 101]. As in with the EPM, anxiety 
is estimated by the exploration of the open versus closed arms.  
 Fewer studies have adopted the EZM to measure anxiety-like behaviors following TBI, and 
they typically find increases in anxiety behaviors. Rats and mice exposed to a bTBI presented 
increased anxiety behavior, quantified as a decreased exploration of the open arm, measured as 
soon as 5 min after the injury [59], and lasting as long as 32 weeks [102]. Studies have found 
both increased and decreased anxiety behaviors following CCI. Male mice and juvenile rats 
exposed to a CCI presented increased anxiety behavior up to 60 days post-injury [9, 103, 104], 
and mice exposed to a weight-drop injury displayed increased anxiety behavior 21 days after the 
injury [67]. However, the opposite effect was observed using both male and female mice [105]: 
in two different studies, authors found decrease in anxiety behavior after CCI and weight-drop 
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injuries, respectively, up to 7 weeks post-TBI. Finally, some studies show no changes in anxiety 
behaviors at 90 days post-injury following a weight-drop injury in mice[85, 106]. 
4.3 Open Field Test 
 The OFT consists of a large box with high walls, and anxiety is inferred by the exploration 
of the exposed center versus the safe periphery of the arena [107]. In the OFT, studies in the 
effect of TBI on anxiety-like behaviors often report a decrease in time spent in the center of the 
arena, suggesting increased anxiety. This effect was observed in juvenile rats, adult rats, and 
mice exposed to CCI, which presented decreased in time spent in the center of the arena up to 
two months after the injury [9, 12, 105, 108-110]. Similarly, rats exposed to LFP and weight-
drop injury presented increased anxiety up to 10 months after the injury [13, 111-113], and mice 
exposed to blast overpressure or weight-drop injury displayed increased anxiety up to two weeks 
later [59, 67, 114, 115]. A few different studies, however, have demonstrated decreased anxiety 
following TBI, measured by an increased exploration of the center of the arena. Rats exposed to 
LFP injury presented increased time in the center and increased number of crossings to the center 
of the OFT at one and three months post-injury [98], and mice exposed to CCI explored the 
center of the arena less ten days [116] and seven weeks after the injury [117]. 
 A significant number of studies have found no effect of TBI on anxiety-like behaviors 
measured in the OFT. This effect has been observed in mice exposed to a mild CCI seven days 
[89], 30 days, and 12 weeks post-injury [108, 118]. Mice and rats exposed to a single [74, 75, 96] 
or repeated [97] LFP showed no change in anxiety up to 12 weeks after the injury. Similarly, 
mice exposed to a closed head concussion model showed no effect in anxiety behaviors up to 
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two weeks [119], and rats exposed to a blast overpressure TBI presented no change up to 17 
weeks after TBI [102]. 
 Studies also report conflicting results regarding locomotion changes in the OFT. Although 
this is not a metric for anxiety, it can be interpreted as an indirect measure of impulsivity [120] 
and used to determine whether locomotion deficits confound changes in anxiety. Immature rats 
exposed to weight drop presented decreased locomotion at day 22 post-injury [68], and mice 
exposed to the same model presented decreased ambulation at day five [71]. Rats exposed to a 
repeated closed-head weight-drop injury showed reduced activity measured by a decrease in total 
distance traveled up to three days for a mild injury and two weeks for a more severe injury [121]. 
They interpret this as an increase in anxiety not associated with motor or sensory deficit; 
however, animals exhibited a significant decrease in locomotion in the open field arena, which 
complicates the interpretation of the results. Rats exposed to an impact acceleration injury 
showed a decrease in distance traveled in the OFT arena at 24h, one week, and four weeks post-
TBI [122], and decreased locomotion was also found in rats exposed to impact acceleration 
injury up to a month after TBI [123]. Finally, mice exposed to CCI and blast injury showed 
decreased locomotion in the OFT 48h post-injury [72]. 
 Whereas some studies have reported decreased locomotion in the OFT, others have found 
hyperactivity in the arena, measured by increased distance traveled or increased number of 
crossings from different zones in the maze. Rats exposed to a closed head weight-drop injury 
presented increased locomotion at 25 to 27 days, with no direct effect on anxiety metrics [82]. 
The same was found in mice exposed to a CCI on day seven [106]. Other studies have found 
increased exploration of the arena one, seven and 14 days post-CCI in mice, with no effect on 
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anxiety [11, 118, 124]. Mice exposed to different levels of CCI (mild, moderate, and severe) 
exhibited increased locomotion up to 21 days post-TBI, accompanied by increased anxiety  [105, 
110, 125]. The same effect was found in rats exposed to a weight-drop model [112]. Perez-Garcia 
and colleagues found a small increase in locomotion in rats exposed to a blast injury up to 32 
weeks post-TBI [102]. In another study, Yu et al. (2012) found that mice exposed to a CCI 
present increased locomotion accompanied by increased anxiety on day ten post-TBI [116]. 
Fromm and colleagues exposed rats to impact acceleration injury plus magnesium injection and 
found increased locomotion at six weeks post-injury [126]. They argue that these results suggest 
a decrease in anxiety in the treated group. However, given that several other studies report an 
increase in locomotion in the OFT post-TBI, with inconsistent results regarding anxiety, it is 
difficult infer that changes in locomotion, regardless of the direction, relates to change in the 
animals’ anxiety state. 
4.4 Light-dark box 
 The LDB consists of a small dark compartment and a spacious, brightly lit region. Anxiety 
is inferred by the amount of exploration of the aversive bright area versus the protected dark 
chamber [127]. Studies on the effect of TBI in the exploration of the LDB box consistently find 
increased anxiety after different injury models, and at diverse time-points. Rats exposed to a 
bTBI presented increase avoidance of the light chamber, both by decreased time spent and 
increased latency to first enter at seven days [128], 11 to 17 weeks [102], and 24 to 29 weeks 
after the injury [80, 129]. Similarly, rats exposed to a mild closed head injury present decreased 
time spent in the light compartment 48h and 30 days post-injury [130]. Mice exposed to a closed 
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head weight drop injury spent less time than shams in the light compartment 19 days after the 
injury [67]. One study, however, found the opposite result: male and female mice exposed to a 
severe CCI spent increased time in the light chamber two days after the injury; however, this was 
accompanied by decreased overall locomotion, which can confound the interpretation of the 
results [125]. 
4.5 Acoustic startle and prepulse inhibition 
 Besides exploration-based tasks, studies on anxiety and TBI have also used acoustic startle 
and prepulse inhibition. In the acoustic startle model, animals are exposed to bursts of noise and 
the intensity of the startle response, or muscle contractions the animal presents in response to the 
loud noise, is indicative of their arousal level [131, 132].  In the prepulse inhibition model (PPI), 
a weak prepulse sound anticipating the startling stimulus is capable of attenuating or suppressing 
the startle response. Importantly, the prepulse inhibition is not affected by habituation or 
extinction [133]. Animals who present higher anxiety will exhibit a decreased attenuation of the 
startle response, indicating heightened arousal. 
 Only a few studies have measured acoustic startle and prepulse inhibition following TBI to 
measure emotional arousal to an aversive stimulus. Those studies find opposing results. On the 
one hand, some have shown decreased startle response following TBI, which suggests decreased 
anxiety. Mice exposed to severe CCI and rats exposed to a bTBI showed a decrease in the startle 
response in the ASR model two to three weeks after the injury [10, 79]. However, other studies 
have found increased arousal to the acoustic stimulus and prepulse inhibition. Mice and rats 
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exposed to a bTBI also presented increased startle response up to eight months after injury [114, 
129]. 
4.6 Fear conditioning 
 Fear conditioning, although not an anxiety metric, has also been often used to test 
emotional responses, as well as memory and learning, following injury [89, 90, 102, 134]. In the 
classical fear conditioning paradigm, an innocuous stimulus (CS), i.e., a tone, is paired with an 
aversive stimulus (US), i.e., a foot shock. After a few co-presentation of the two stimuli, the CS 
starts to elicit the innate response previously associated only with the US, i.e., freezing response. 
The proportion of time the animal freezes to both the CS and the context in which conditioning 
occurred are indicative of the animal’s level of fear, and the animal’s ability to remember the CS-
US pairing [135].  
 Most studies adopting a fear conditioning paradigm and TBI try to emulate post-traumatic 
stress disorders, which is also a common neuropsychiatric disorder following injury [81, 102, 
136]. However, there is no consensus on how close injury and fear exposure should be, and in 
which order they should be paired (TBI first, followed by fear conditioning, or vice-versa). Here, 
we summarize the studies that have adopted a fear conditioning paradigm in combination with 
TBI, regardless of the order or time-point used. For each study, we point out the temporal 
relation between injury and fear conditioning, and their findings. 
 Part of the studies demonstrates that animals exposed to different types of TBI and then 
trained on a fear conditioning paradigm show a decrease in fear expression during the testing 
phase. In one study, mice exposed to LFP were trained in a fear conditioning paradigm one week 
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or one month after the injury. At one week, there was no difference in freezing behavior between 
control and experimental groups during the training session, in response to both the context and 
the cue, indicating they were able to learn the CS-US association. Two days after conditioning, 
TBI animals presented less activity suppression when re-exposed to the context than controls, 
indicating a weaker fear response. However, groups did not differ in response to the cue when 
tested one week later. By one month, both groups presented the same levels of activity 
suppression to both the context and the cue, indicating a transient effect of the injury in 
contextual fear [137]. Rats exposed to LFP and trained in a fear conditioning paradigm five days 
later presented a marked decrease in freezing when they were re-exposed to the same context 
[138]. This effect was observed for as long as 42 days after the injury [139]. One study exposed 
mice to CCI and tested them in a contextual fear conditioning task 28 to 29 days after the injury. 
Although there was no difference between the groups during training, TBI animals displayed a 
significant decrease in freezing to the context when they were re-exposed 24h after training 
[140]. 
 Another study exposed mice to a mild CCI and trained them in a fear conditioning 
paradigm three weeks after the injury, then re-exposed them to the same context and cue 24h and 
six weeks later. TBI animals presented typical acquisition, compared to both sham and naive 
controls. However, 24h later, in the testing phase, TBI animals exhibited significantly less 
freezing to the cue. After groups went through full extinction, they were re-exposed to the cue. 
TBI animals presented a resurgence of their fear response, measured by a significant increase in 
their freezing behavior, and indicating a long-term extinction deficit in those animals [84].  In 
another study, mice were exposed to repeated blast injury and trained on a fear conditioning 
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paradigm 23 weeks after the injury. Repeated TBI animals did not differ from sham in the 
proportion of freezing during acquisition, but they presented a significant reduction in freezing 
during cue and context re-exposure [39]. Genovese and colleagues trained rats in a food-
maintained variable interval operant conditioning task, then in a fear conditioning paradigm. 
After conditioning, animals were exposed to three days of mild repeated bTBI. Animals were 
then tested to measure their conditioned response to the CS every week for two months. Animals 
exposed to bTBI presented a decreased expression of conditioned fear to the cue, measured by 
decrease in response suppression in the operant conditioning task [136]. In these examples, the 
acquisition was not impaired, which suggests no learning deficit. However, animals presented 
less freezing during re-exposure to the cue, which could indicate a sensory deficit, deficit in 
memory recall, decreased anxiety, or deficit in risk assessment. 
  Some other studies, on the other hand, have reported increased in fear acquisition and 
expression following TBI. Mice and rats exposed to a bTBI were trained in a fear conditioning 
task, eight weeks or 35 weeks after the injury. TBI animals did not differ from controls during 
the acquisition phase, but they exhibited increased freezing and slower extinction during the re-
exposure phase for the cue test, and mice, but not rats, also froze more to the context compared 
to controls [102, 114]. Rats exposed to a fear conditioning procedure two to eight days after an 
LFP or a mild weight-drop injury presented increased and overgeneralized fear, measured by 
increased freezing to the context and the cue, measured by enhanced freezing on the test and 
extinction days, with no difference between groups in the training day and regardless of the 
intensity of the foot-shock [141, 142]. Mice exposed to mild CCI were tested in a fear 
conditioning paradigm 14 days after the injury. They presented enhanced fear during acquisition 
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and context extinction, as well as increased freezing after the reinstatement of the CS-US pairing 
following extinction [143]. Mice exposed to CCI and trained in a fear conditioning protocol at 
day 40 showed enhanced contextual fear measured by increased freezing on day 42, but no 
difference between groups in response to the cue [144]. 
 Unpredictable stress or a social stressor have been adopted as a way to simulate the 
stressful condition some TBI patients experience. In one study, mice were exposed to 
unpredictable stressors for 21 days, and they were trained in a fear conditioning paradigm on day 
12, during stress exposure. On the same day, they were exposed to mild CCI. Nine days after the 
injury, they were re-exposed to both the context and the cue used during fear conditioning. There 
was no difference between TBI only, TBI with unpredictable stress, and the control group during 
context testing, but animals exposed to stress combined with TBI presented increased freezing to 
the cue compared to controls [81]. Davies and colleagues exposed rats to a social defeat 
procedure, shortly followed by a mild weight-drop TBI to emulate the stressful condition that is a 
hallmark for PTSD. They were then tested in a fear conditioning paradigm seven days after the 
injury. Groups did not differ during acquisition, but animals that were exposed to the injury alone 
or social defeat combined with injury presented more freezing during the first day of re-exposure 
to the context. On days two and three of extinction exposure, only animals exposed to social 
defeat with TBI presented enhanced freezing, indicating that TBI-only animals presented normal 
extinction compared to controls.  [66] 
 In some studies, there was no difference between TBI and control animals during fear 
conditioning. Mice exposed to severe CCI and trained in a fear conditioning paradigm either 24h 
before the injury or two weeks after did not differ from sham animals in the percentage of 
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freezing to the cue, both during acquisition and when they were tested during the extinction 
phase 16 days after CCI [89]. In a different study, male and female mice were exposed to either 
single or repeated mild closed-head frontal impact or CCI and tested for contextual and cue fear 
conditioning four weeks after injury. There was no difference between TBI and controls during 
acquisition, cue, and context extinction, regardless of the type of injury [119]. Finally, mice 
exposed to different levels of CCI (mild, moderate, and severe) and tested on a fear conditioning 
protocol 38 days later did not differ in the acquisition, context and cue extinction [145]. 
4.7 Differences in behavioral metrics 
 An issue that these results highlight is that even when the same behavioral assay is used,  
different metrics of anxiety behavior can be used in reporting the results. For instance, Jones et 
al. (2008) report an increase in the number of crossings to the center of the OFT arena after an 
LFP in rats suggesting decreased anxiety. Ajao et al. (2012) reported increased anxiety in the 
OFT measured by the decrease in the total distance traveled in the first 3 min in the OFT in rats 
exposed to CCI. Almeida-Suhett et al. (2014) reported increased anxiety measured by the 
decrease in the time spent in the center of the arena. While this is not a problem exclusive to TBI, 
but an overall challenge for translational models [146, 147], those differences add a layer of 
complexity when interpreting results across studies. Reporting change in distance traveled as a 
metric of anxiety is a particular issue, since it is not possible to infer the animal’s anxiety level 
by its ambulation. Locomotion is a confounding factor for anxiety and can obscure the 
interpretation of the animal’s internal state [148]. Therefore, it is important to report well-
established and validated metrics of anxiety, such as the proportion of time in the anxiogenic 
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zone, as well as to report metrics such as the number of entrances, head-dips, and locomotion as 
additional or control measurements.  
 The ultimate goal of measuring behavioral differences is to understand the underlying 
neural mechanisms of injury that lead to these outcomes. In the next section, we will discuss 
some of the neural markers that have been  utilized in studies of anxiety outcomes following 
injury. 
 Because of the complexity of TBI pathology, the effect of the injury changes over time. 
However, most studies measure anxiety after TBI only from the first few hours up to about a 
month after injury. For example, in the OFT, only a fifth of the studies shown in Table 1 tested 
anxiety for longer than a month after injury [9, 13, 73, 95, 102, 111, 126, 129]. While 
understanding the acute behavioral and neuropathological effects of injury is fundamental, there 
are crucial delayed structural and functional alterations that also need to be elucidated [52]. In 
clinical TBI, patients can suffer from psychiatric disorders for years after the injury [149]. 
Therefore, to bridge the translational gap from animal models to clinical application, and to 
develop appropriate treatments to help patients recover from the adverse effects of injury, more 
studies need to address the long-term effects of injury, as well as identify the behavioral and 
neurological progression of the injury. 
5. Neural markers 
 TBI is followed by a series of morphological, structural, and physiological changes in the 
brain. Cell loss and volumetric changes in various brain regions have been associated with 
anxiety-dysfunction following TBI. Meyer and colleagues (2012) exposed rats to a mild weight-
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drop injury, and they found that the increased expression of anxiety-like behaviors and 
conditioned fear was accompanied by a significant neuronal cell loss in the CA1 region of the 
dorsal hippocampus, besides increased cell number and volume in the amygdala nine days after 
injury [141]. Juvenile rats exposed to CCI showed a decrease in NeuN-positive cells near the 
injury and the ipsilateral and contralateral parietal cortex, indicating a cell loss in those regions. 
They also found a decrease in corpus callous size and decrease thickness of white matter tracks, 
measured by the neural process marker NF200. Those alterations in the neuronal number and 
axonal conduction underlie the behavioral changes following injury, more precisely, the 
increased anxiety two months after the injury [9]. Rats exposed to a moderate LFP displayed 
increased anxiety that was associated with a decrease in cortical volume in the barrel cortex, 
hippocampus, and corpus callosum, both in the ipsi and contralateral side, measure via MRI [13]. 
Ten-day old animals exposed to a weight-drop injury exhibited an increase in cell death and 
decreased brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), markers of 
neural growth and maturation, in regions CA1, CA3, and DG of the hippocampus, four days after 
the TBI, accompanied by decreased anxiety [70]. Another study observed that the increase in 
anxiety levels were accompanied by a decrease in neuron density in the amygdala, prefrontal 
cortex, and hippocampus, associated with high serum corticosterone levels, markers for stress 
response, three weeks after TBI [68]. 
 TBI is a complex pathology that involves primary and secondary injury processes. While 
the primary injury encompasses the damage caused at the time of the impact to the head, the 
secondary injury involves several biochemical processes that lead to neural cell death, gliosis, 
white matter degeneration and axonal damage [150, 151]. One of the best-documented effects of 
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the secondary injury following TBI is an increase in oxidative stress in the hours following the 
injury [152]. Oxidative stress in the ipsilateral cortex following a moderate weight-drop injury 
model has been reported in mice 24h after the post-TBI, assessed by a significant increase in 
TBARS, a byproduct of reactive oxygen species activation. Two weeks after the injury, they 
found an increase in an anti-oxidative marker (GPx) in the ipsilateral hippocampus [83]. The 
molecular changes were accompanied by decreased anxiety, measure by an increase in 
exploration of the open arm in the EPM, 12 days after the injury. The increase in oxidative stress 
is a known secondary effect of TBI in the short term [153], and the increase in antioxidant 
markers can indicate a protective mechanism against the oxidative damage induced by TBI.  
 Another important sequela of TBI is neuroinflammation [154]. Rats exposed to a repeated  
mild LFP model showed an increase in microglia and macrophages, measured by increased ED1-
labeled cells, a marker for inflammation in the injured cortex 24h after the injury, but not two 
months later [75]. Those changes were not accompanied by any effect on anxiety. Another study 
measured microglia activation and axonal damage after single or repeated injuries. By using 
silver degeneration staining, they found axonal degeneration in the external capsule and corpus 
callosum for both single and repeated injury. Iba-1 immunostaining, a microglia marker, showed 
an increased activation bilaterally in the amygdala [90], indicating that the amygdala, a hub for 
emotional responses deep in the brain, even when not directly affected by the injury, can suffer 
significant changes that may underlie the observed alterations in anxiety-like behaviors. Axonal 
degeneration was also observed three to eight weeks after blast injury, accompanied by increased 
fear and anxiety  [114]. This type of damage is a marker of diffuse injury, commonly observed in 
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mild human TBI. An increase in Iba-1–positive cells around the lesion site has also been reported 
following CCI in animals who displayed increased anxiety [104].  
 Other inflammation markers have also been identified, such as increase in inflammatory 
cytokine, interleukin-1b (IL-1b) 12h and 24h after TBI, as well as increase in GFAP, a hallmark 
of gliosis, and OX-42, a marker for glial cell reactivity, in several brain regions, including the 
hippocampus, amygdala, and insula, which was accompanied by increased anxiety [124, 155]. 
Animals injected with a glial-cell activation inhibitor (MN166) had their behavioral deficits 
reversed, suggesting a role of inflammation and gliosis on anxiety-like behavior  post-TBI [155].  
 Of particular interest to this work are the changes in GABAergic and glutamatergic 
neurotransmitter systems. It is well established that these systems  play a fundamental role in the 
development of anxiety disorders  [156, 157] and they are disturbed after TBI [12, 86, 134, 158],  
Evidence proposes a central role of gamma-aminobutyric acid (GABA), the primary inhibitory 
neurotransmitter in the nervous system, in the control of anxiety, suggesting GABA 
dysregulation as a hallmark of anxiety disorders [159]. Inactivation of the basolateral nucleus of 
the amygdala by muscimol injection increases exploration of the anxiogenic zone in the elevated 
plus-maze, and the light-dark chamber [160], and decreased GABA-a receptor in the 
hippocampus, parahippocampus and orbitofrontal cortex leads to increased anxiety in the 
elevated plus maze, free-choice exploration and light-dark chamber, measured by an increased 
avoidance of the anxiogenic zones or novel object. [161]. Those studies point out that GABA 
deficiency in several limbic areas is linked to deficits in anxiety, whereas positive modulation of 
GABA, via GABA agonist injections, for instance, has an anxiolytic effect [162, 163]. A few 
studies have measured GABAergic transmission changes after TBI. Notably, Almeida-Suhett and 
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colleagues, who exposed rats to a mild CCI, correlated the increased anxiety observed in the 
OFT with hyperexcitability in the BLA, measured by loss of GABAergic interneurons and 
reductions in the frequency and amplitude of inhibitory postsynaptic currents (IPSCs). Besides 
the decrease in inhibitory signaling, they also found a significant increase in the surface 
expression of nicotinic acetylcholine receptor (a7- nAChR), implying an increase in the 
excitability of principal neurons within the BLA [12]. Another study also found decreased 
GABAergic signaling after a CCI-like injury, however, and importantly, in this study, animals 
were treated with progesterone and presented decreased anxiety in the EPM. Progesterone also 
led to a decrease in the edema caused by the injury, suggesting a protective role of progesterone 
after TBI [86].   
 The damage caused by the secondary injury often leads to excitotoxicity mediated by 
excessive glutamate release [164]. However, studies often find a downregulation of glutamate 
following TBI in animals who present alterations in anxiety behaviors, despite hyperexcitability 
of the amygdala being a hallmark of anxiety and fear [158]. Limbic and paralimbic structures, 
such as the amygdala, hippocampus, and medial prefrontal cortex are highly formed by 
glutamatergic pyramidal neurons [165]. Studies suggesting the involvement of glutamate in the 
control of anxiety show that glutamate antagonists injections into limbic brain areas, as well as 
intraperitoneal injections of mGLUR and NMDA antagonist, have an anxiolytic effect [128, 166, 
167]. However, many studies in TBI have found a down-regulation in glutamatergic signaling, 
indicating an increased inhibition, which was often accompanied by increased anxiety. Mice 
exposed to a CCI presented changes in the excitatory marker PSD-95, which is involved in the 
maturation of excitatory synapses and promotes glutamatergic transmission. A decrease in 
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PSD-95 expression in the ipsilateral hippocampus was found beginning seven days post-injury. 
The loss of PSD-95 was also accompanied by a decrease in NeuN staining.; and correlates to the 
behavioral deficits, in particular to this review, the increase in locomotion in the OFT [118]. 
Animals exposed to CCI and blast injury also presented a decrease in PSD-95 [104] and a 
decrease in excitatory neurons in the BLA, measured by the expression of Thy1+ pyramidal 
neurons [114], all accompanied by increased anxiety. Mice exposed to a moderate CCI presented 
increased excitability in the lateral amygdala three months after the injury, assessed by the an 
increase in spontaneous excitatory postsynaptic currents (sEPSCs), suggesting increase in 
glutamatergic signaling [168]. Nevertheless, another study caused a weight-drop injury in 10-day 
old animals, and observed a decrease in N-methyl-D-aspartate receptor (NMDAR) 
immunoreactivity four days after injury, [70]. Contradicting those results, Reger et al. (2012) 
exposed rats to fear conditioning and concussive brain trauma and observed the upregulation of 
excitatory NMDA receptors in the BLA and the hippocampus. Behaviorally, these animals 
presented an increase in fear conditioning and over-generalization of fear to a novel stimulus 
[134].  
 Those results suggest that hyper- and hypo-excitability caused by the imbalance between 
GABA and glutamate in limbic areas may play a vital role in the control of anxiety in the murine 
brain. How the balance between these two neurotransmitters is affected by the injury concerning 
anxiety remains unknown.  
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6. Challenges in comparing studies: differences and common factors 
 Anxiety outcomes of TBI in animal models continue to present a series of challenges to 
researchers, due to the considerable complexities in modeling and measurement. Table 1 presents 
a summary of all the findings discussed above, demonstrating how heterogeneous the anxiety 
outcomes of TBI are.  Factors such as differences in injury model and severity, behavioral assays 
and time-points, all play a role in the observed discrepancies in anxiety outcomes.  
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 Clinically, anxiety is recognized as a complex, multifaceted neuropathology that manifests 
itself in a range of forms, from generalized anxiety disorder to social anxiety and specific 
phobias [169].  Given this complexity, it is likely that in animal models, behavioral assays 
following TBI may be picking up on different facets of anxiety [170]. Besides concerns with 
sensitivity, and identification of state or trait anxiety, in these tests [62, 171, 172], behavioral 
measures in anxiety assays can also be  confounded by changes in general activity, like 
locomotion, grooming, and eating [62]. Ramos (2008) defends the idea that emotionality, 
including anxiety, is multidimensional. In clinical anxiety, this is already recognized, and 
diagnostics guidelines, such as the Diagnostic and Statistical Manual (DSM), divide anxiety 
disorders based on distinct causes and environmental triggers. Extrapolating this logic to animal 
models of anxiety, Ramos (2008) proposes that anxiety varies in several independent axes, that 
are only accessible if we test animals in a battery of assays that bring about different contextual 
stressors (height, bright and open spaces, novelty, etc.). 
 Exposure to the injury itself, may be a complicating factor, by affecting the animals in ways 
that make traditional interpretations of their behavior in anxiety assays difficult. For instance, 
while human studies on sleep deprivation consistently point to an anxiogenic effect, animal 
models fail to replicate those findings, and often the results are contradictory [173]. Sleep 
researchers thus suggested that deprivation creates a complex phenotype, in which anxiety can 
co-occur with impulsivity or other disorders. In those cases, traditional anxiety metrics are not as 
informative. It is possible that TBI also leads to a complex phenotype, and that, in order to assess 
the effects of TBI on anxiety, we need an improved understanding of the anxiety assays applied 
to these models.  
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 In addition, animals may present an individually variable response to the injury. This idea is 
well documented and accepted in clinical studies of TBI associated anxiety dysfunction. Patients 
who suffer TBI present different levels of vulnerability to anxiety following injury [7, 174]. 
Animal models of psychiatric disorders recognize this importance of individual differences 
among subjects [147, 175, 176]. In the field of stress, researchers have found that not all the 
animals exposed to a stressor will develop an anxious phenotype [175]. Therefore, they started to 
separate animals based on their behavior outcome after the exposure to a stressor. One of the 
most commonly used approaches to identify behavioral differences among stressed animals is the 
cutoff behavior criteria (CBC), developed by Cohen and colleagues [177-179], allowing for the 
identification maladapted and well-adapted subsets of the stressor exposed population [180]. 
Maladapted animals can be thought of as vulnerable to stress, while well-adapted animals are 
resilient to the effects of stress. This approach has allowed researchers to identify important 
behavioral, genetic and molecular differences between maladapted and well-adapted animals. 
For instance, different strains of rats present different levels of vulnerability to the stressor [178], 
vulnerable animals present higher levels of cortisol and HPA-axis activity [181], and early life 
stress increases the chances of animals to develop vulnerable phenotype later in life [182].  
 To summarize, we posit that there are three types of challenges to the interpretation of the 
anxiety outcomes of TBI in animal models. First, anxiety is likely a multifaceted pathology, and 
behavioral assays, when used individually, may fail to give a complete picture of the animal’s 
emotional state. Second, the injury likely adds a level of complexity to the behavioral outcomes 
that are not captured without a range of behavioral assays. Third, the injury may have 
idiosyncratic effects on animals, leading to variability in terms of outcomes among animals. 
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 To address the issues regarding the complexity of anxiety, some authors have proposed a 
multidimensional approach to anxiety, in which different behavioral assays are combined to 
capture different, but potentially overlapping aspects of anxiety [183, 184]. Ramos (2008) 
proposes that the animal models of anxiety most commonly used do present commonalities, but 
they are more effective when used in combination. Addressing the same issue, Cryan and 
Holmes (2005) argue that innate anxiety assays, although convenient for their ease-of-use, 
present challenges that may complicate interpretation of the results.  They also propose the use of 
a battery of behavioral tests of anxiety, in order to increase reproducibility and better elucidate 
the animal’s emotional state. We adopt this approach in the first part of our study, to characterize 
the time and task dependent response pattern of animals following a CCI model of injury. The 
diversity in injury models and severity of injury are integral to capturing the range of  injuries 
that can occur in the real world.   However, by keeping the differences among these in mind, 
using a diverse battery of assays, and measuring along both early and extended time-points, we 
can ascertain that a complete and accurate picture of the affective sequelae associated with TBI is 
captured. 
 Another important issue is that of variability in response to injury. When we take a closer 
look at the way animal studies are analyzed, we find that animal studies measuring anxiety 
response following TBI traditionally report the statistical comparison between TBI animals and 
their sham counterparts post-injury, and infer differences between the two groups (see examples: 
[12, 14]). However, such an approach is not informative about the individual responses to injury, 
and ignores the potential for the presence of sub-groups with different response patterns. To 
address this, we propose an approach inspired by the one adopted by the CBC: separating 
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animals exposed to TBI based on the effect the injury has on their anxiety levels, but generalize 
it to work on multidimensional behavioral data. We adopt a battery of behavioral tests and time-
points, and use a dimensionality reduction method and clustering algorithm to identify 
vulnerable and resilient animals based on their behavioral profiles. Further, we study the 
relationship of several molecular markers in brain areas associated with anxiety behavior (mPFC, 
BLA, vHPC) with these behaviorally identified vulnerable and resilient subgroups. 
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Chapter 2: Methods and materials 
1. Subjects 
 A total of 103 adult male C57BL6J mice (Jackson Labs, Bar Harbor, ME, USA) were 
used in the experiments. Animals belonged to two different batches. Table 2 summarizes the 
number of animals in each batch. Experiments reported in chapter three used the first batch of 
animals. Batch two was added for experiments presented in chapter four. Mice were split in two 
groups, CCI and sham, and the number of animals per batch are shown in Table 2.  They were 
housed in colonies of four, with CCI and sham animals mixed in the same cage, in a 12 h light 
cycle (lights on from 7 am to 7 pm), with constant temperature and humidity (22°C and 40%). 
Food and water were available ad libitum. Animals’ weight was monitored weekly, averaging 32 
g. Mice were 6–8 weeks-old at the beginning of experiments and allowed 2 weeks of acclimation 
before experiments began. Behavioral testing was conducted between 10 am and 5 pm. This 
study was carried out in accordance with the recommendations of IACUC guidelines. All 
experimental procedures were approved by Johns Hopkins Animal Care and Use Committee. 
Table 2: total number of animals per experimental batch, per condition (CCI and sham controls) 
Total number of 
animals
Number of CCI 
animals
Number of sham 
animals
Batch 1 42 25 17
Batch 2 61 46 15
Total 103 71 32
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2. Injury Procedures 
 Animals underwent anesthesia under two different conditions. The first cohort of animals 
were anesthetized with Avertin (2,2,2 tribromoethanol - Sigma, St.Louis, MO) diluted in isotonic 
saline (500 mg/kg, i.p.), whereas the second cohort was anesthetized via 3% isofluorene. After a 
midline skin incision, a circular craniotomy was made midway between Bregma and lambda 
with the medial edge of the craniotomy 0.5 mm lateral to the midline. The mice were then 
subjected to a moderate to severe [14, 118, 185] CCI injury using a convex impactor tip of 3 mm 
in diameter. The injury was generated using the following parameters: 4.5 m/s velocity, 1.50 mm 
depth of penetration and a sustained depression for 150 ms. Mice were given 1 ml saline and 100 
µl of 10% Meloxicam subcutaneously. Body temperature was maintained at 37°C with a 
warming blanket until full recovery from anesthesia (recovery of righting reflex). Sham-operated 
controls underwent the same surgical procedures with the exception of the traumatic injury. After 
surgery, mice were kept in individual cages for 72 h and monitored daily, then returned to their 
home-cages. Survival rate for the surgeries were about 90%. Righting times for both groups for 
recovery from anesthesia and surgery were similar (CCI: 101 ± 7.09 min; Sham: 103 ± 1 9.17 
min). All surviving animals (71 CCI group, 32 sham control group) underwent further behavioral 
testing following recovery. 
3. Behavioral Tests and Apparatus 
 Baseline and post-injury behavioral testing were performed with all mice - TBI and sham 
- together, in the same order each week. Testing proceeded as follows: animals were brought into 
the experimental room at least 30 min before the experiments began. They were first tested in the 
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OF, and given at least 2 h to recover before testing on the EZM. Twenty-four hours later, they 
were brought back to the experimental room and tested in the EPM. Mazes were cleaned with 
70% ethanol between each animal. Each mouse was tested twice in each maze before injury. 
Baseline testing was performed 5–7 days apart, and injury was induced one week after the last 
baseline test. Baseline values were averaged for each animal to calculate their individual baseline 
level of anxiety. 
3.1 Open-Field Test (OF—Accuscan, Columbus, OH) 
 The apparatus consisted of a 40.6 cm × 40.6 cm sound-attenuating box, with sensors on 
the bottom that monitored the animals’ movement. A computer connected to the device recorded 
time spent in the center and distance traveled. Mice were placed in the center of the field and 
allowed to freely explore for 20 min. There were two trials before injury and four biweekly trials 
after injury. 
3.2 Elevated Plus Maze (EPM) Test 
 Apparatus consisted of two intersecting runways (50 cm × 50 cm × 5 cm), placed at 1 m 
from the ground. One runway had no walls (two open arms), while the other had 20 cm dark, 
high walls (two closed arms). Mice were placed in the center of the maze, facing one closed arm, 
and allowed to explore for 10 min. There were two trials before surgery and four biweekly trials 
after. A camera placed above the maze recorded the animal’s movement, and trials were analyzed 
using Ethovision© software. Behavioral metrics monitored were total distance traveled, distance 
traveled, number of entrances and time spent in each arm. 
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3.3. Elevated Zero-Maze (EZM) Test 
 Apparatus consisted of a circular platform (width: 5 cm, inner diameter: 40 cm), placed at 
1 m from the ground and divided in four quadrants. Two opposite quadrants had a 20 cm dark, 
high walls (closed arm), while the other two had no walls (open arms). Mice were placed facing 
the entrance of a closed arm, and allowed to explore for 10 min. There were two trials before and 
four biweekly trials after surgery. A camera placed above the maze recorded the animal’s 
movement, and trials were analyzed using Ethovision© software. Behavioral metrics monitored 
were total distance traveled, distance traveled, number of entrances and time spent in each arm. 
4. Anatomical Metrics and Immunohistochemistry 
4.1 Fixation and Sectioning 
 Two weeks after behavioral testing was finished, mice were deeply anesthetized (2.5% 
Avertin, 250 mg/kg body weight, i.p., Sigma, St. Louis, MO, USA) and transcardially perfused 
with 1 M phosphate buffer saline (PBS, 50 ml) followed by 4% paraformaldehyde (PFA, 100 ml, 
Sigma, St. Louis, MO, USA). Brains were removed and post-fixed in 4% PFA (50 ml) for 72 h, 
then transferred to a solution of 30% sucrose in 4% PFA, where they were kept refrigerated until 
sectioning. Coronal sections (40 µm) of the whole brain were taken using a slide microtome 
(Leica Microsystems, model CM-1860). 
4.2 Immunohistochemistry 
 The primary antibodies used and their concentrations were: anti-GAD65/67 (1:1000, 
EMD Millipore), anti-vGLUT (1:1000, Thermofisher), and anti-Neuropeptide-Y (1:000, 
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ABCAM). Mounted sections were washed 3 times for 10 min each wash in 0.1M PBS and then 
incubated in blocking solution. For GAD65/67 and vGLUT, we used a blocking solution 
containing 10% normal goat serum and 0.5% Triton X-100 in PBS for 2 h at room temperature. 
For NPY, sections were blocked with a Mouse on Mouse immunodetection kit (Vector Labs) to 
reduce endogenous staining, for 1h at room temperature. Slides were then be incubated with 
primary antibody, in 10% normal goat serum for GAD65/67 and vGLUT, and 5% mouse IgG 
blocking reagent for NPY, in 0.5% Triton X-100, for 72 h at 4° C. After incubation, the sections 
were rinsed three times in PBS for 10min, and incubated with the secondary antibody, with the 
appropriate blocking serum, 0.5% Triton X-100, for 2 h in room temperature. The secondary 
antibodies used were Alexa Fluor 488 (1:1000, Abcam) for GAD6567 and vGLUT1, and Alexa 
Fluor 405 (1:1000, Abcam) for NPY. Sections were washed three times for 10 min with PBS, and 
incubated for 30 min with NeuroTrace 640/660 Deep-Red Fluorescent Nissl (Thermofisher) and 
mounted with Vectashield antifade mounting medium (Vector Labs). Separated, consecutive 
sections were used for each antibody. 
5. Imaging for Volumetric Measure 
 Fluorescent images of the brain in the peri-injury region were taken with an Axiozoom 
v16 microscope (Carl Zeiss, Germany) using a 10× objective. Volume estimation was performed 
as described previously [186], adopting Cavalieri estimation [187]. Images from four sections 
were taken for each mouse in each area. We determined the position of each section by using 
Mouse Brain Atlas coordinates [188]. Sections were located between −0.70 and −2.46 mm 
Bregma, and they contained the lesioned area in the injured mice or equivalent position in sham 
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controls. BLA images were taken between −1.22 and 2.18 mm Bregma. Images were pre-
processed using Fiji software (Schindelin et al., 2012). The hemispheric and BLA areas were 
outlined using Fiji on the ipsilateral and contralateral sides of the four brain sections, volume was 
calculated as the sum of the areas multiplied by the distance between sections (300 µm). The 
ipsilateral volume was normalized to the contralateral volume to estimate the extent of 
hemispheric volume loss (lesion) and change in BLA volume. 
6. Imaging for Immunohistochemistry 
 Fluorescent images of the BLA, mPFC and vHPC were taken with a Zeiss LSM 700 
microscope (Carl Zeiss, Germany) using 40x objectives. Four bilateral immunofluorescent 
labeled sections were taken in each mouse (8 images per animal per region, per marker), sections 
were approximately 200 um apart. Images were pre-processed using Fiji, and masks were 
generated for each image [189]. Number and intensity of puncta were calculated using a custom 
MATLAB analysis package (IMFLAN3D) [190]. A ‘punctum’ was defined as a cluster of 
‘connected’ pixels identified in an unbiased manner using the MATLAB function bwlabeln with 
the ‘eight-connected neighborhood’ criterion.  
7. Statistical Analysis 
7.1 Experiment 1 
 For the behavioral tasks, a two-way unbalanced repeated measure ANOVA was 
performed after standard methods of outlier exclusion in MATLAB were applied. Data shown (at 
each time point in Figures 3.1, 3.2 and in Figures 3.3 and 3.4) represent distributions obtained 
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after removal of outliers following a standard procedure in MATLAB: samples that deviated 
from the median by more than fac*interquartile range were deemed outliers (average value of fac 
used = 1.5). Post hoc t-tests were performed whenever ANOVA indicated a significant effect, and 
p-values were corrected by a false discovery rate (FDR) test. For hemispheric volume, the 
normalized ipsilateral volumes (ipsilateral/contralateral) were compared among groups using t-
tests and FDR correction. For GAD65/67 puncta analysis, the mean of each group was compared 
using t-test with FDR correction. Individual baseline data was averaged across the two pre-injury 
sessions to determine the mean value for each animal and assay. Post-injury behavioral data was 
plotted normalized to each animal’s individual baseline: behavioral metrics at each time-point 
was divided by the animal’s baseline value. Values greater than one indicate the mouse’s anxiety 
level decreased in comparison to its baseline, whereas values smaller than one indicate increase 
in anxiety. This approach allows us to measure how anxiety changed for each individual animal 
because of the injury. Normalized values are presented as mean ± standard error (SEM). All 
statistical tests were performed using MATLAB (Mathworks Inc., Natick, MA, USA). Statistical 
analysis was considered significant for p < 0.05. 
7.2 Experiment 2 
 For the behavioral tasks, a three-way unbalanced repeated measure ANOVA was 
performed. Post-hoc t-tests were performed whenever ANOVA indicated a significant effect, and 
p-values were corrected by a false discovery rate (FDR) test. For hemispheric volume, the 
normalized ipsilateral volumes (ipsilateral / contralateral) were compared among groups using 
three-way ANOVA, and t-tests with FDR correction were used whenever a significant difference 
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was found. For the puncta analysis, the mean of each group was compared using three-way 
ANOVA and t-test with FDR correction. Individual baseline data was averaged across the two 
pre-injury sessions to determine the mean value for each animal and assay. Post-injury 
behavioral data was plotted normalized to each animal’s individual baseline: behavioral metrics 
at each time-point was divided by the animal’s baseline value. Values greater than one indicate 
the mouse’s anxiety level decreased in comparison to its baseline, whereas values smaller than 
one indicate increase in anxiety. This approach allows us to measure how anxiety changed for 
each individual animal because of the injury. Normalized values are presented as mean +- 
standard error (SEM). All statistical tests were performed using MATLAB (Mathworks Inc., 
Natick, MA). Statistical analysis was considered significant for p<0.05.  
7.3 Principal component analysis and k-means clustering 
 PCA is a statistical procedure that uses an orthogonal linear transformation to convert 
correlated observations into uncorrelated variables (or principal components, PCs). Each PC 
explains a part of the variability in the dataset, with the first accounting for the most variability, 
and successive PCs accounting for progressively smaller amounts. We combined the behavioral 
metrics in the EZM and OFT on weeks one, three, five and seven, and EPM on weeks three, five 
and seven into one 11-dimensional vector, which we refer to as the animals’ behavioral profile. 
We applied PCA to the dataset constituting the behavioral profiles of all the TBI animals, and 
found that the first four principal components together accounted for a majority (Cohort A: 92%, 
Cohort B: 87%) of the total variability in the dataset. We then applied a clustering algorithm (K-
means) to identify two distinct clusters of animals (because we were interested in the extreme 
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responders, we asked the algorithm to cluster the data optimally into two clusters). For the 
‘control PCA’, we performed an independent analysis (PCA and k-means) on the behavioral 
profile of sham animals. 
7.4 Effect size (Eta-squared) 
 In order to determine the magnitude of the immunostaining results, following a three-way 
ANOVA and post-hoc testing, we calculated the effect size (eta-squared, η2) for each comparison 
between resilient, sham and vulnerable animals. Eta-squared was calculated using the Effect Size 
toolbox  v1.6.1 [191], and the function mes2way, in Matlab ©, following the formula: 
We report the strength of effect sizes follows: small (η2 = 0.02), medium (η2 = 0.06), and large 
(η2 = 0.14) [192]. 
7.5 Correlation analysis 
 We calculated the correlation between the behavioral data on the EZM on week seven 
with all the instances where we found a statistically significant difference between vulnerable 
animals and resilient or sham controls. We chose the EZM because it was the behavioral metric 
that presented the most consistent results, and week seven was the closest time-point to the 
immunostaining procedure. We calculated Person’s linear correlation coefficient using the 
Matlab © function corr. We adopt the criteria of r>06 for a strong correlation, and 0.2<r>0.6 for 
a weak to moderate correlation [192].  
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Chapter 3: Long-Term Effects of Traumatic Brain Injury on Anxiety-Like 
Behaviors in Mice: Behavioral and Neural Correlates 
1. Introduction 
 Traumatic brain injury (TBI), characterized as any damage to the brain caused by 
external acceleration or deceleration forces [15, 193], is a complex health problem affecting 
millions of people worldwide [2]. TBI produces considerable and wide-ranging losses in 
cognitive, motor and affective functions [194, 195]. This is true even of injuries considered mild 
or moderate, which constitute 80% of all cases and can lead to debilitating long-term effects 
[196, 197]. The high prevalence and substantial impact of TBI emphasize the importance of 
understanding the neural mechanisms underlying the outcomes of injury. 
 Animal models of TBI, and specifically rodent models, have been used to replicate the 
human symptomatology, examine neural mechanisms and test therapeutic interventions [16]. The 
cognitive and motor outcomes of TBI have been well established and replicated among pre-
clinical studies [198-200]. However, affective outcomes, and specifically, maladaptive anxiety 
outcomes, which can affect up to 70% of all TBI patients [6, 7, 201, 202], have been difficult to 
reproduce in animal models. Studies in rodents, which typically quantify anxiety as the 
proportion of time animals spend in a more exposed, anxiogenic portion of a behavioral 
apparatus, as opposed to an enclosed, less anxiogenic zone, have yielded inconsistent and, at 
times, contradictory results [9-12, 88, 89, 108, 118, 203, 204]. 
 One group of pre-clinical studies found an increase in anxiety-like behaviors following 
TBI. Injured rats and mice spent less time than sham controls in the anxiogenic zones in the open 
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field test (OFT), elevated plus maze (EPM), elevated zero maze (EZM) and in the dark-light 
chamber tests, and exhibited increased immobility in the tail suspension test for up to 8 weeks 
post-TBI [9, 12, 108, 203, 204]. Paradoxically, another group of studies found a decrease in 
anxiety-like behaviors, with injured animals spending more time than sham controls in the 
anxiogenic zones in the EPM and OFT for up to 3 weeks post-TBI [10, 11, 118]. Finally, a third 
group of studies found no difference between injured and sham animals in the EPM and OFT for 
up to 6 weeks post-TBI [88, 89, 203]. It is likely that the diversity in range of time-points tested - 
ranging from 3 to 8 weeks; and differences in the choice of behavioral tests administered to 
assess anxiety account for these variations. Together, they contribute to the idiosyncratic results 
reported in the literature. An additional factor that can add to variation is the degree of injury 
severity, which differs between studies. However, even for a similar injury level, variable results 
have been described. Wagner et al. (2007), Ajao et al. (2012) and Almeida-Suhett et al. (2014) 
produced mild controlled cortical impact (CCI) in rats and found increased anxiety at 7 days 
[12], at 14 days [108] and up to 60 days [9].  
 However, Amorós-Aguilar et al. (2015) produced a mild CCI in rats and found no effects 
on behavior. A moderate to severe CCI can lead to no anxiety early after injury [89], increased 
anxiety at 45 days [104], or variable effects depending on the test used [125]. Washington et al. 
(2012) explicitly tested this by using varying levels of injury severity. While severity impacted 
lesion volume differentially, behavioral effects at 3 weeks after injury were similar. Mild, 
moderate or severe injury leads to reduced anxiety in the EPM at 21 days post injury, and 
showed no effects in the OFT. However, moderate or severe injury showed greater lesion 
volumes and decreased ipsilateral hippocampal volumes, as compared to mild injury. 
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 The primary goal of this study was to explicitly address the issues of variability in time-
points and behavioral assays in mice. We hypothesize that there is a time and test dependance of 
anxiety-like behaviors measured following CCI. To achieve this goal, we used a well-established 
model of brain injury—the CCI model [16, 35], employed a battery of commonly used tests to 
measure anxiety-like behaviors in mice, and measured anxiety over a long time-course. Anxiety 
behaviors were assessed every 2 weeks up to 7 weeks following moderate to severe injury, and 
all mice were subjected to a battery of OFT, EPM, and EZM tests of anxiety at each time point. 
This experimental design permitted the direct comparison of different anxiety metrics within the 
same animals and over time, allowing for a systematic dissection of the behavioral affective 
sequelae of anxiety following injury. Repeated measures of anxiety tests, on one hand have been 
interpreted as leading to habituation in response. However, this is also associated with changes in 
assessment of threat in the anxiogenic zone and implies the development of a learned form of 
fear response [205], which has implications for anxiety behavior. Additionally, following this 
behavioral characterization, we also measured a molecular marker of GABAergic function in the 
basolateral amygdala (BLA), one of the key hubs of anxiety processing, to gain a window into 
the molecular underpinnings of changes in anxiety-like behavior following injury. 
 Our results support the central hypothesis of this study, by demonstrating that early 
effects on affective behavior following injury can differ from late effects, and that the observed 
effects can vary depending on the behavior test used. Consequently, they reveal a complex 
picture regarding the affective consequences of injury, and argue for the need for a standardized 
and comprehensive approach to study affective outcomes of TBI in animal models. 
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2. Results 
2.1 Effects of TBI on Anxiety-Like Behaviors Exhibit a Complex Trajectory 
 We determined the long-term effects of TBI on affective outcomes in a battery of innate 
anxiety behavioral tests following exposure to a CCI injury. Mice were tested in the OFT, EZM 
and EPM tests. These tasks exploit the animals’ natural conflict between seeking protection and 
exploring a novel environment. All mice were tested twice in the behavior tests before surgery, 
and these were averaged to determine each animal’s baseline level of anxiety. Post-injury or 
sham surgery, they were then tested on weeks 1, 3, 5 and 7. Anxiety was measured by the change 
in proportion of time they spent in the anxiogenic zone in each assay, as well as number of 
entrances to the open arm (EZM and EPM). Values at each time point are normalized to each 
animal’s baseline; this approach allowed us to determine how the anxiety level of each animal 
changed due to the injury. We controlled for possible locomotion deficits, by measuring total 
distance traveled in all three mazes. 
 Examples of heat maps representing the proportion of time TBI and sham mice spent in 
each zone in the OFT arena on week 7 are illustrated in Figure 3.1A. In this test, we found an 
overall effect of injury across the population, tested by an repeated two-way ANOVA (F(1,3) = 
4.04, p < 0.01, Figure 3.1B). Injured mice spent significantly more time in the center of the arena 
on week 7 (post hoc t-test with FDR correction, p = 0.02), but we did not observe difference 
between groups in the other time-points. These results indicate that the main effect of injury was 
driven by the strong decrease in anxiety TBI mice presented on week 7. 
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 In order to compare the effect of injury across different behavioral assays, we measured 
anxiety-like behaviors in the EZM and EPM tests. Heat maps illustrating the proportion of time 
mice spent in each type of arm are shown in Figures 3.1C, E. In the EZM, there was no main 
effect of injury in the proportion of time spent in the open arm (repeated two-way ANOVA, F = 
0.002, p = 0.96, Figure 3.1D). However, we found a strong interaction effect between time and 
injury (repeated two-way ANOVA, F(1,3) = 4.24, p < 0.01). TBI mice display increased anxiety 
on week 1 (post hoc t-test with FDR, p < 0.01) and decreased anxiety on week 5 (post hoc t-test 
with FDR correction, p = 0.01), as measured by time spent in the open arms. Interestingly, in 
both the OFT and EZM, we observed a decrease in anxiety-like behaviors as compared to sham 
controls, on week 7 and 5, respectively, which suggests a delayed effect of the injury. There were 
no differences between groups in baseline, prior to TBI. 
 In addition to the OFT and EZM tests, we measured anxiety in the EPM. Figure 3.1F 
shows the proportion of time mice spent in the open arm in this assay. We found a main effect of 
injury, tested by a repeated two-way ANOVA (F(1,3) = 4.44, p = 0.03), and a strong effect of 
time (repeated two-way ANOVA, F(1,3) = 9.18, p < 0.01). Post hoc t-test with FDR correction 
showed that TBI mice spent significantly less time in the open arm on week 3, indicating 
increased anxiety (p < 0.05). We observed that both in the EZM and EPM tests, there was an 
increase of anxiety-like behaviors on earlier time-points: on week 1 for the EZM and week 3 in 
the EPM. Across the 3 behavioral assays, our results indicate that the effects of TBI on anxiety-
like behaviors are time- and task-dependent: generally, TBI led to an early increase and late 
decrease in anxiety-like behaviors. 
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Figure 3.1. Traumatic brain injury (TBI) causes long-term effects on affective behaviors. 
(A,C,E) Representative heat maps of TBI and Sham animals in the open field (OFT), elevated 
zero maze (EZM) and elevated plus maze (EPM), respectively. Warmer colors represent that the 
animals spent more time on that zone. (B) Proportion of time in the center of the OFT arena. 
Each circle represents one mouse. Horizontal bars denote means; shaded regions denote SEM. 
There is a main effect of injury (repeated two-way ANOVA, p < 0.01) and anxiety significantly 
decreases on week 7. (D) Proportion of time in the open arm of the EZM; conventions as in 
(B). There is an interaction between time and injury (repeated two-way ANOVA, p < 0.01). 
Anxiety is significantly increased on week 1 and decreased on week 5. (F) Proportion of time 
in the open arm of the EPM; conventions as in (B). There is a main effect of injury and time 
(repeated two-way ANOVA, p < 0.01). Anxiety significantly increases on week 3. Panels 
(B,D,E) show data are from n = 25 mice in TBI condition, and n = 17 mice in sham condition 
after removal of outliers at each time point (“Materials and Methods” section); the number of 
outliers at any time point for any condition did not exceed four mice; *p < 0.05, **p < 0.01 by 
post hoc t-test with false discovery rate (FDR) correction.
 As an additional metric of anxiety, we measured number of entrances to the open arm in 
the EZM and EPM. Injured mice did not differ from sham on number of entrances in the EPM 
(repeated two-way ANOVA, F(1,3) = 0.25, p = 0.61, Figure 3.2D). In the EZM, we observed an 
effect of injury in the number of entrances to the open arm (repeated two-way ANOVA, F(1,3) = 
5.10, p = 0.02, Figure 3.2E), and TBI mice presented significantly fewer entrances on week 1 
(post hoc t-test with FDR correction, p = 0.01), which is consistent with the decreased anxiety 
observed in the proportion of time in the open arm on week 1 in this maze. 
 To ensure that anxiety metrics were not affected by locomotion deficits, we measured 
total distance traveled in each maze. In the OFT, TBI led to hyperactivity throughout all time 
points (repeated two-way ANOVA, F(1,3) = 36.69, p < 0.01, post hoc t-test with FDR correction, 
p > 0.05, Figure 3.2A). Injury had no locomotion effect on the EZM (repeated two-way ANOVA, 
F(1,3) = 0.56, p = 0.45, Figure 3.2B) and EPM tests (repeated two-way ANOVA, F(1,3) = 1.23, 
p = 0.26, Figure 3.2C). Since TBI and sham did not differ in terms of total distance traveled in 
the EZM, we concluded that the reduced number of entrances to the open arm in this maze 
reflects the increase in anxiety those mice presented on week 1. Finally, we concluded that the 
effects in anxiety-like behaviors were not confounded by locomotion deficits. 
 Our behavioral results indicated that the effects of TBI in anxiety-like behaviors are 
complex. Although injury did not affect locomotion in the EPM and EZM tests, the effect on 
anxiety metrics varied across time-points and assays. By comparing different assays, we 
identified that in the first few weeks after injury, mice had a significant increase in anxiety-like 
behaviors. This effect, however, inverted after about a month post-injury. After this point, TBI 
mice display decreased anxiety-like behaviors as compared to sham controls. 
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Figure 3.2. TBI effects vary across behavioral assays and metrics. (A) Total distance traveled in the 
OFT. There is a main effect of injury (repeated two-way ANOVA, p < 0.01), and TBI animals 
travel more at all time-points compared to sham controls. (B,C) Total distance traveled in the EZM 
and EPM, respectively. There is no effect of injury in locomotion in these assays. (D) Number of 
entrance to the open arm in the EZM. There is a main effect of injury (repeated two-way ANOVA, 
p < 0.05) and TBI animals present fewer entrance on week 1 than sham controls. (E) Number of 
entrances to the open arm in the EPM. There is no effect of injury. In all panels, each circle 
represents one mouse. Horizontal bars denote means; shaded regions denote SEM. Data from n = 
25 mice in TBI condition, and n = 17 mice in sham condition are shown after removal of outliers at 
each time point (“Materials and Methods” section); the number of outliers at any time point for any 
condition did not exceed three mice; *p < 0.05, **p < 0.01.
2.2 Injury Was Consistent Across Mice 
 Considering the complex effects of injury, we asked if differences in the extent of injury 
across mice could be a confounding factor. Because we were interested in the long-term effects 
of injury, we sacrificed the mice on week 9 post-injury or sham surgery, obtained brain sections 
and quantified hemispherical volumes as an anatomical metric of the extent of injury. 
 Coronal brain sections of an injured mouse illustrating the extent of the injury to the 
cortex and hippocampus, as well as a brain section in the same region of control mouse are 
presented in Figures 3A,B. We determined the extent of the injury by measuring the hemispheric 
area of the peri-injury site, on the ipsilateral and contralateral sides of four brain sections per 
mouse, located between −0.70 and −2.46 mm Bregma, and multiplied the sum of the areas for 
each side by the distance between sections (300 µm; n = 10 for each group). The ipsilateral 
hemispheric volume of each brain was then normalized to its contralateral side. There is no effect 
of injury on the contralateral side (data not shown). The injury caused a reduction of the 
ipsilateral hemispheric volume of approximately 20%, compared to control mice (Figure 3.3C, 
two-tailed t-test, p < 0.01). The extent of the injury was consistent among TBI mice, as shown by 
the standard error of the mean (SEM TBI = ±0.04, SEM sham = ±0.01). 
2.3 Injury Did Not Cause a Volumetric Change in the BLA 
 We proceeded to identify potential neural correlates of the long-term behavioral 
outcomes. Past work has demonstrated that injury can cause volumetric changes in brain areas 
distal from the site of injury. Motivated by this, we hypothesized that the affective behavioral 
changes could correlate with anatomical changes in the BLA, a key brain area involved in the  
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Figure 3.3. Controlled cortical impact (CCI) causes consistent injury across animals and no 
volumetric change in the basolateral amygdala (BLA). (A) 12× panoramic coronal sections 
stained with Fluoro Nissl, representing the lesion in the cortex and hippocampus for TBI 
animals and (B) intact areas in sham controls. (C) Hemispheric volume in TBI and sham 
animals. There is a significant reduction in the ipsilateral hemisphere volume of injured 
animals, compared to sham controls (t-test, p < 0.05). (D) Volumetric measure of the BLA. 
Injury does not cause volumetric change in the BLA of TBI animals. Bar graphs in (C,D) show 
mean ± SEM of data from n = 10 mice in the TBI condition and n = 10 mice in the sham 
condition after removal of outliers (“Materials and Methods” section); the number of outliers 
did not exceed one mouse for any condition; *p < 0.05.
control of emotional responses. To test this hypothesis, we measured volumetric changes in the 
BLA on week 9. 
 Volume of the BLA was estimated by measuring area of four sections on each side per 
mouse, and multiplying the area of the BLA by the distance between sections (300 µm). BLA 
sections were located between −1.22 and −2.18 mm Bregma. The ipsilateral volume was then 
normalized to its contralateral side (n = 10 for each group). There is no effect of injury on the 
contralateral side (data not shown). There was no significant difference in BLA volume between 
injured and sham mice, as shown in Figure 3.3D (two-tailed t-test, p = 0.7). These results 
indicate that the changes in anxiety-like behaviors were not correlated with changes in volume in 
the BLA. 
2.4 Neural Marker: Immunostaining Indicates Upregulation of GAD Ipsilaterally 
 Next, we assessed functional neural correlates of the long-term affective outcomes of 
injury. To investigate whether the observed late decrease in anxiety had a molecular correlate, we 
examined the strength of inhibitory signaling in the BLA. To this end, we performed GAD 
immunostaining by targeting GAD65/67, which are two enzymes expressed in the brain and 
involved in the synthesis of GABA. GAD67 is expressed equally through the cell body, while 
GAD65 is mainly found in nerve terminals [206]. We chose to target GAD because it has been 
demonstrated that GABA plays a crucial role in anxiety disorders [157]. We quantified several 
metrics of GAD expression, such as number and intensity of GAD puncta. Ipsilateral values were 
normalized to contralateral for each mouse. 
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Figure 3.4. TBI is associated with upregulation of GAD immunostaining in the ipsilateral 
amygdala. (A) Middle column: 10× images of histological sections from a sham animal (top) and 
TBI animal (bottom). Left/Right columns: 63× views of the indicated portions of the sections. 
Fluoro Nissl staining in purple and GAD65/67 staining in green. (B–G) Quantification of 
GAD65/67 expression in the ipsilateral and contralateral BLA in four sections per animal. Metrics 
in (B–G) are reported as ratios of ipsilateral to contralateral values for each animal. In injured 
animals, there was a significant increase in the total number of GAD pixels (B) and the total 
intensity of GAD pixels (C), but not the average intensity of GAD pixels (D). In addition, there 
was an increase in the total number of GAD “puncta” (clusters of contiguous GAD pixels (E), but 
not in the average size of puncta (F) or average intensity of puncta (G). All bar graphs show mean 
± SEM of data from n = 10 mice in the TBI condition and n = 10 mice in the sham condition after 
removal of outliers (“Materials and Methods” section); the number of outliers did not exceed two 
mice for any; *p < 0.05 (two-tailed t-test).
 Figure 3.4A shows coronal sections zoomed-in on the BLA, with labeling of cell bodies 
and GAD puncta for a sham and a TBI mouse. There was an overall increase in the total number 
of GAD-stained pixels in the ipsilateral BLA of injured mice, measured by a two-tailed t-test (p 
= 0.03, Figure 3.4B. There was also an overall increase in total GAD signal intensity (p = 0.01, 
Figure 3.4C). Notably, the average intensity of GAD-stained pixels was not different between 
groups (p > 0.05, Figure 3.4D). Together, these results indicate that injury causes an increase in 
the number of GAD-stained pixels, but not in the intensity (brightness) of individual pixels. 
 To understand if there were effects on spatial clustering of GAD-stained pixels, we next 
analyzed the properties of groups of contiguous (or connected) GAD-pixels, called “puncta” (see 
“Materials and Methods” section). Compared to individual pixels, which can be contaminated by 
noise, puncta are more likely to represent functional signal. We found that there was an increase 
in the number of GAD puncta following injury (Figure 3.4E, p = 0.04), but no change in the 
average size of puncta or the average intensity of puncta (p > 0.05, Figures 3.4F,G). In other 
words, consistent with the results from individual pixels, GAD puncta are not larger or brighter, 
they are greater in number following injury. Together, the immunostaining results show an 
upregulation of GAD immunostaining in the ipsilateral BLA of TBI mice. 
3. Conclusion  
 Human TBI has a complex pathology, and studies show that, among the many outcomes 
of injury, patients are at a higher risk of suffering from anxiety disorders [6, 7, 201]. Reports on 
the prevalence of anxiety following injury are variable: pooled long-term prevalence is reported 
at 36%, according to a recent review [6], but some studies suggest prevalence between 11% and 
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70% [7]. One unsolved issue is our lack of understanding about the neural mechanisms of injury 
that may increase a patient’s chance of developing an anxiety disorder. Animal models of TBI are 
valuable to address this problem, for their ability to control for injury parameters and to allow us 
to measure behavioral changes and neural markers in well-controlled experiments. However, a 
complex, and at times contradictory, picture has emerged from various animal studies. It is 
important to comprehensively study these models over long time frames, to develop an 
understanding of TBI pathophysiology and its impact on affective behavior. 
 In this study, we adopt a well-established and highly controlled mouse injury model 
(CCI), and test mice in three assays of innate anxiety over a 7-week time-course, to evaluate how 
the evolving consequences of TBI impacts affective behavioral function. We demonstrate that the 
effects of moderate to severe TBI on anxiety-like behaviors are complex and long lasting. 
Additionally, with this behavioral characterization as a basis, we also measured a molecular 
marker of GABAergic function in the BLA, one of the key hubs of anxiety processing, and we 
demonstrated that there is an upregulation of GAD staining at 9 weeks post-injury. 
 Early after TBI, injury caused a significant increase in anxiety-like behavior measured in 
the EPM and EZM tests, consistent with several studies that show increased anxiety acutely after 
injury to the murine brain [12, 125, 141]. However, no such effect was observed in the OFT. This 
is consistent with Sierra-Mercado et al. (2015), who tested the effect of CCI in mice 1 week after 
injury, and found no change in anxiety as measured by the OFT. Interestingly, a few other studies 
are able to measure this early increase in anxiety in the OFT as well [12, 108, 125]. This 
inconsistency could be explained by differences in severity of injury [125] or rodent model [12, 
108]. However, the difference between effects observed among behavioral tests in our study—
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within the same group of mice at the same time points—underlines the complexity of measuring 
anxiety-like behavior in animal models. An important potential implication of this finding is that 
different assays of anxiety do not always measure the same aspect of anxiety-like behaviors. A 
comprehensive approach to behavioral testing following TBI is therefore imperative to draw 
useful conclusions. In order to study the progression of the anxiety response following injury, it 
is necessary to employ a repeated testing model. One concern with repeated measurement for 
behavioral tests of anxiety is that of potential habituation and learning. While repeated testing 
has been shown to have effects on anxiety tests in many studies [64, 207, 208], Bertoglio and 
Carobrez (2000) suggest that the decreased exploration of open arm in the EPM could be related 
to a qualitative shift from unconditioned to a learned form of fear response[205]. Thus, what is 
generally considered habituation or learning in the testing arena, is likely a change in the 
acquired fear response underlying the expression of anxiety-like behavior. Changes in the sham 
group over time suggest that some of these factors do play a role in this study. Sham mice 
presented habituation to the OFT and EPM, observed in the decrease in proportion of time spent 
in the anxiogenic zone over time post-surgery on the OF and EPM, as well as in decrease over 
time in the total distance traveled in the OFT. These results are consistent with previous 
literature, which has demonstrated that repeated exposure to the OFT and EZM lead to 
adaptation to the apparatus measured by decreased exploration of the anxiogenic zone and 
decreased overall locomotion [209-212]. 
 While this study does not rule out these factors in the testing arena, that effect is 
consistent between both sham and injured groups, and differences observed between groups can 
be attributed to the TBI. Changes in the expression of anxiety behavior can therefore be 
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interpreted as a deficit in the learned fear response due to re-exposure, a deficit in learning about 
the context of the anxiogenic zone, or as an increase in risk taking behavior. Direct assays 
measuring changes in fear learning, such as acoustic startle, might help to parse out these 
changes over time. 
 The affective response to TBI is not limited to the early time points, but evolves over 
time, reflecting the fact that neural mechanisms of injury evolve over time [18]. Five weeks after 
TBI, injured mice show significantly less anxiety-like behaviors. At this stage, the mice showed 
an increase in exploration of the open arm in the EZM test, as compared to sham controls. The 
mice also display an increased tendency to explore the center anxiogenic zone in the OFT. 
Curiously, a similar increase in exploration of the open arm is not observed in the EPM test. Our 
findings are consistent with findings of decreased anxiety-like behavior in the EZM test at later 
time points after injury [73, 104], as well as decreased anxiety in the OFT in rats exposed to 
lateral fluid percussion at 1 and 3 months post-injury [73]. Interestingly, several studies have 
found decreased anxiety in the EPM as well, tested in mice following CCI at 20 days [10] and 
rats tested in a closed-head model at between 12 and 30 days [82, 83]. This difference could also 
be explained by the fact that we use repeated measurements of behavior in the EPM. Similarly, 
Ajao et al. (2012) measured an initial increase in anxiety like behavior after juvenile rats were 
exposed to CCI, which appears to reverse at later time points[9]. 
 Injury also caused increased locomotion in the OFT throughout all time-points, consistent 
with other studies [73, 82, 125]. This suggests that the observed hyperactivity is independent of 
the early increase and later decrease in anxiety-like behavior. These findings are consistent with 
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human studies where hyperactivity has been reported following pediatric TBI [213] and 
impulsivity has been reported following TBI in adults [120, 214]. 
 Several neural mechanisms underlying anxiety changes following injury have been 
investigated [9, 12, 14, 70, 80, 83, 134, 141]. Of particular interest is the BLA, which has been 
linked to changes in anxiety-like behaviors. Causal manipulations of projections from and to the 
BLA directly alter anxiety-like behaviors [215-219], indicating that this area is an important hub 
for emotional responses in the brain. In addition, signaling by GABA, the major inhibitory 
neurotransmitter in the nervous system, is greatly implicated in psychiatric disorders such as 
anxiety and depression [156, 157, 159, 220]. Infusion of GABAA receptor antagonist into the 
amygdala increases anxiety [221], whereas GABA agonist infusion into the BLA reduces anxiety 
[222], indicating that the inhibitory balance within the amygdala drives changes in anxiety. In 
previous TBI studies, it has been shown that reduced GABAergic inhibition and increase in 
number of neurons in the BLA correlate with enhanced anxiety in rodents early after injury [12, 
141]. 
 In this study, while the volumetric measures of the peri-injury area indicate a reduction in 
ipsilateral hemispheric volume as expected [10, 12, 222], there is no significant difference in 
volumetric measures of the BLA between injured mice and sham controls. However, GAD 
immunostaining is upregulated in the ipsilateral BLA at 9 weeks following injury, indicating 
increased GABAergic inhibition within this area. This increase is correlated with late decreases 
in anxiety-like behavior of the injured animals at later time points. Our results are consistent with 
causal, GABAA agonist infusion experiments in the BLA [47]. Almeida-Suhett et al. (2014) 
observed TBI-induced decrease in GABAergic inhibition and an increase in anxiety-like 
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behavior at early time points after injury, whereas this study shows the opposite effects at later 
time points. Thus, our results regarding GABA signaling are in line with previous work and 
extend our understanding about the longer-term effects of injury. 
 In summary, we demonstrate a time-dependent reversal in the course of affective 
behavioral response following traumatic injury to the mouse brain: an early increase followed by 
a late decrease in anxiety, with the latter being correlated with an increase in GABAergic 
inhibition in the BLA. In addition to revealing a complex affective trajectory, results support the 
hypothesis that the lack of consensus across past studies [10, 73, 82] on the effects on anxiety 
outcomes following injury may be the result of the variability in injury models used, behavioral 
assays of anxiety chosen and time-points at which assessments were made. Consequently, they 
highlight the need for the use of a reproducible model of injury as well as the use of multiple 
assays and time-points within future studies. Such an approach can provide a consistent 
foundation for investigating the neural mechanisms underlying affective outcomes of TBI and 
the development of therapeutic strategies. 
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Chapter 4: Resilience and vulnerability in anxiety outcomes of TBI 
1. Introduction 
 Neuropsychiatric disorders are a significant outcome of traumatic brain injury (TBI), and 
may develop months to years after the incident [7, 174]. Among the neuropsychiatric outcomes 
of TBI, anxiety-related disorders are highly prevalent and impose significant impairments to 
patients. Some studies report the prevalence of anxiety-related disorders after TBI ranges 
between 10% to 70% [223], and a recent meta-analysis suggests that the pooled prevalence of 
anxiety following TBI is 20% in the first year, and 36% five years post-injury  [6]. Those results 
indicate that, although the prevalence of anxiety disorders post-TBI is high, only a sub-set of TBI 
patients will be affected. Therefore, clinical studies aiming to address anxiety outcomes of TBI 
adopt rigorous exclusion criteria, such as structured interviews and scales, to determine which 
patients should be included in studies [224, 225]. On the other hand, pre-clinical studies of TBI 
and anxiety-like behaviors have generally included the entire injured population as a 
homogenous group, and the physiological or molecular sequelae discussed as a function of the 
injury.  
 A variety of effects has been reported in anxiety-like behaviors in these studies, 
suggesting that heterogenous responses within the injured group may be a factor [10, 12, 14, 73, 
82, 88, 141]. Here, we aim to address this issue by developing an approach analogous to the use 
of inclusion criteria in clinical studies. In a mouse model of controlled cortical impact injury, we 
measure a multidimensional behavioral profile which is then clustered and validated to 
distinguish between sub-groups of injured animals. Our results suggest that this alternative, data-
driven approach to analyzing dysfunction in anxiety-like behaviors following traumatic brain 
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injury, allows us to distinguish subjects that present maladaptative anxiety after the injury from 
those that are unaffected by the injury, and that we can subsequently measure distinctions in 
molecular markers between these sub-groups. 
A number of pre-clinical studies have addressed the impact of brain injury on changes in 
anxiety-like behavioral responses. These studies report a large range of effects, from decreased 
anxiety following a controlled cortical impact injury [10] and weight-drop injury [82] at 20 to 30 
days post-TBI; increase in anxiety following weight-drop [141], lateral fluid percussion [13], and 
blast overpressure [79], up to 3 months after later; and no change on anxiety on animals exposed 
to a CCI [89], repeated weight-drop [90] and LFP [96], up to 3 months after injury. We have 
previously demonstrated this complexity in observed anxiety outcomes, demonstrating a time 
and task-dependent trajectory in response [117]. We found that the TBI group demonstrates an 
increase in anxiety-like behavior early after injury, followed by a decrease at later time-points 
[117]. However, consistent with previous approaches to analyzing behavioral dysfunction, this 
study compares injured and sham groups, disregarding any potential variability in injury 
response within the injured group. 
 We began to question whether the approach of treating the injury group as one, obscures 
the effect of heterogeneity in behavioral response following injury. Such distinctions in response 
to a common stimulus have been described in studies analyzing the effects of psychological 
stress [175, 177, 181]. The notion of individual differences in response to a stressor has been 
defined in the neurobiological and psychological literature as resilience [226, 227], or the 
organism’s ability to adapt to adversity. Resilient individuals cope better with stressful events,  
being able to adapt to extreme situations, whereas vulnerable individuals present higher risk of 
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some types of psychiatric disorders, in particular anxiety and depression [228]. Thus, maladapted 
or well-adapted subjects can also be described as having different levels of resilience to the 
stressor, which leads individuals exposed to extreme situations to present potentially opposing 
behavioral outcomes following exposure to the same stressor [227]. 
Several insights about the underlying mechanisms leading to resilience and vulnerability 
to psychological stressors have been identified using approaches leveraging heterogeneity. To 
identify these sub-groups, arbitrarily selected severity measures, the cut-off behavioral criteria 
(CBC), were used to distinguish subjects that are well-adapted or maladapted in their response to 
a common stressor [175]. The observed response in the elevated plus maze and in the acoustic 
startle response determine if they present a maladapted or well-adapted behavior profile. Animals 
who present high avoidance to the open arm, and increased startle response are deemed 
maladapted, or low-responders, whereas animals who present no change compared to controls 
are considered well-adapted, or high-responders. These behaviorally defined sub-groups, who 
were subjected to an identical stressor, show distinctions in physiological measures as increased 
plasma corticosterone and ACTH levels, increased sympathetic activity, diminished vagal tone 
and increased sympathovagal balance [96].   
The prevalence of extreme (maladapted) responders across different strain of rats varied, 
and reductions were associated with a blunted hypothalamic pituitary axis response to stress 
[178]. Early post-stressor intervention with a selective serotonin reuptake inhibitor was found to 
reduce incidence of extreme behavioral responses [229]. Early-life exposure to stressors led to an 
increased vulnerability to developing a maladapted phenotype and persisting physiological 
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abnormalities later in life, and was associated with a failure of recovery from the initial 
autonomic nervous system response to stress exposure [182]. 
 Such research supports the development of an approach that defines behavioral criteria 
addressing the variance in individual response pattern and magnitude, following the exposure to 
traumatic injury. Classification of animals exposed to injury into definable groups, presenting 
vulnerability or resilience in their behavioral responses, allows for focused study that 
incorporates the underlying heterogeneity. Based on our previous findings [117], several 
different assays and metrics of anxiety are measured over time to give rise to a multi-dimensional 
behavioral profile. We therefore need to use principal component analysis followed by clustering 
to identify unique sub-sets within this multi-dimensional dataset. This is followed by validation 
of the distinctness of these clusters by plotting the individual behavioral metrics for each 
separately. Identification of behaviorally distinct sub-sets allows us to then further probe 
distinctions in molecular signaling in several brain regions known to be associated with anxiety-
like behavior, such as the medial prefrontal cortex (mPFC), the basolateral amygdala (BLA), and 
the ventral hippocampus (vHPC) [218, 230-232]. Activation of ventromedial prefrontal cortex-
amygdala (vmPFC-Amy) pathway and amygdala reactivity have been associated with behavioral 
adaptation and vulnerability to neuropsychiatric disorders [218, 231]. Modulation of GABA and 
glutamate activity in various limbic areas is associated with anxiety-like behaviors [157, 165, 
206, 233-237]. On the other hand, neuropeptide Y has been identified as a marker of resilience in 
behavioral outcomes to stress exposure [181, 238, 239]. We characterize the molecular signatures 
of signaling via GABA (GAD65/67), glutamate (vGLUT), and neuropeptide Y (NPY), which are 
all known to be involved in changes in signaling in anxiety response or resilience [181, 
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Figure 4.1: Approach for dividing tbi animals into two groups based on multidimensional 
behavioral profile A) Top: Schematics of experimental timeline, including baseline behavioral 
testing, injury, post-injury behavioral testing and immunostaining procedures. Bottom: schematics 
of behavioral matrix used as input for PCA analysis. Behavioral data on the EZM, OFT and EPM 
were combined to generate a behavioral profile for each animal.
238-240]. Our results suggest that behaviorally identified resilient and vulnerable sub-groups 
following injury show distinct changes in these molecular markers. Moreover, there is a 
significant correlation of the molecular change with the extent of behavioral change in the 
vulnerable group. 
2. Results 
 Mice were first tested on three commonly used behavioral assays for anxiety, namely, the 
EZM, OFT and EPM [62, 107, 207]. Metrics of anxiety-like behaviors as well as of general 
locomotion were measured before injury (Fig. 4.1A), and were denoted as ‘baseline’ 
measurements. A week following the baseline measurements, animals underwent either sham 
surgery (‘control’ group) or CCI injury (‘TBI’ group); mice were assigned randomly to the two 
groups. After a week of recovery, all animals were tested on the three behavioral assays, once 
every two weeks for a period of seven weeks following injury, resulting in four measurement 
time-points post-surgery (sham or TBI). Mice were sacrificed at 8 weeks after injury. In previous 
work [117], we have shown that effects of injury on anxiety-like behaviors are time- and task-
dependent, and follow a complex trajectory.  Additionally, while habituation to the testing arena 
was observed in OFT and EPM, it was consistent across sham and injury groups.  However, this 
approach does not allow us to distinguish if the individual response to injury varied between 
animals in the TBI group. In this study, we use a multi-dimensional clustering approach to 
address this question. For each animal, behavioral measurements were normalized to their 
respective baseline values to account for pre-surgery variability across animals.  
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Figure 4.2: TBI animals present distinct behavioral profiles, indicating different levels of vulnerability 
to anxiety following TBI. A) First three principal components on surgery cohort A and B, showing TBI 
animals separated into two clusters. B) Proportion of time in the anxiogenic zone for surgery cohort A. In 
the EZM (left), there was a main effect of treatment (F=19.89, p=0), and vulnerable animals present 
decreased anxiety compared to resilient animals on all weeks (*: p<0.05). In the OFT (center), there was a 
main effect of treatment (F=10.06 p=0), and anxiety was decreased for vulnerable animals compared to 
resilient animals on weeks three and five (p<0.05). In the EPM (right), there was a main effect of treatment 
(F=120.07, p=0), and vulnerable animals presented decreased anxiety compared to resilient animals on all 
time-points (p<0.05). C) Proportion of time in the open arm in the anxiogenic zone, combining surgery 
cohorts A and B. In the EZM, (left), there was a main effect of treatment (F=95, p=0), and vulnerable 
animals had decreased anxiety compared to shams and resilient animals in all time-points (* and #: p<0.05). 
In the OFT (center) there was a main effect of treatment (F=8.37, p=0.0003), and vulnerable animals 
presented decreased anxiety on week one (p<0.05). In the EPM (right), there was a main effect of treatment 
(F=12.45, p=0), and vulnerable animals were significantly less anxious compared to shams on weeks three, 
five and seven and to resilient animals on all time-points  (p<0.05). D) Number of entrances to the open arm 
in the EZM (left) and EPM (right), combining cohorts A and B. There was a main effect of treatment in the 
EZM (F=3.92, p=0.02), and vulnerable animals had more entrances than shams on week five, and more 
entrances than resilient animals on weeks three, five and seven (p<0.05), and no effect in the EPM p=0.18, 
F(2)=1.68. E) Proportion of time in the anxiogenic zone in the anxiogenic zone during baseline. There was a 
main effect of treatment in the EZM (left, F=4.97, p=0.008), with vulnerable animals showing increased 
anxiety compared to sham and resilient animals (p<0.05), but there was no effect of treatment on the OFT 
(center) and EPM (right). F) Ipsilateral hemispheric volume in comparison to contralateral side. There was a 
significant reduction in volumetric hemisphere for both resilient and vulnerable animals, in comparison to 
sham animals (p<0.001), however, resilient and vulnerable animals did not differ from each other (p=0.67). 
Lines represent p<0.05 for difference between groups with post-hoc t-test with FDR correction. Bars 
represent SEM, * represents p<0.05 for vulnerable versus resilient, # represents p<0.05 for vulnerable 
versus sham after post-hoc t-test with false discovery rate (FDR) correction. All data presented includes 
outliers. Behavioral data is normalized to each individual animal’s baseline. Data from 103 animals (sham: 
n=32, resilient: n=62, vulnerable: n=9)
2.1 Identification of two behaviorally distinct sub-groups (vulnerable and resilient) following 
TBI, based on a multidimensional behavioral profile of each individual.  
 The proportion of time that mice spend in the exposed zones of behavioral arenas – open 
arms of the EZM and EPM, and the central zone of the OFT – is a standard metric used to 
quantify their anxiety-like behaviors [14, 62, 101, 107, 207]. We refer to it generally as 
‘proportion of time spent in the anxiogenic zone’. Our post-injury measurements (baseline-
normalized) of this metric across mazes and time points yielded a 11-dimensional behavioral 
vector or ‘profile’ over time for each mouse. We asked if, based on their multidimensional 
behavioral profiles, we could identify distinct groups within the TBI cohort: one exhibiting 
substantial affective behavioral consequences of injury, and another being largely resistant to 
effects of injury. To address this question, we developed an unbiased data-driven approach.  
 We obtained the 11-dimensional behavioral profile for  Cohort A of 37 TBI animals (and 
15 sham animals; animals assigned to conditions randomly), and organized this data into 37x11 
behavioral profile matrix (for TBI animals, and 15x11 matrix for shams). We started the analysis 
by performing principal components analysis on this multidimensional dataset for TBI animals 
(in this case, 37 x 11) to determine the smallest number of behavioral dimensions that accounted 
for most of the variability in the data. We find that 92% of the variance was explained by just 4 
of the 11 dimensions (Fig. 4.2A). Next, we applied k-means clustering to the lower dimensional 
dataset (of principal components; 37x4) to force the identification of two distinct clusters. Since 
PCA transforms data points into a new coordinate frame, it was not possible, a priori, to 
determine whether the clusters in PCA space represented low- and high-responders, and if so, 




Figure 4.3: Clustering sham animals does not produce behaviorally distinct groups. A) PCA 
done independently on sham animals, for surgery cohort A and B separately. Animals were then 
clustered into two separated groups by k-means, similarly to the procedure applied for TBI 
animals. B) Proportion of time in the anxiogenic zones comparing cluster 1+A versus cluster 
2+B. In the EZM (left) and EPM (right) there was no main effect of treatment (EZM: F=0.95 
p=0.33; EPM: F=1.14 p=0.28) In the OFT (center), there was a small effect of treatment (F=8.8 
p=0.003), with no post-hoc effect. C) Proportion of time in the anxiogenic zones, combining 
cluster 1+B versus cluster 2+A.  In the EZM (left), there was no main effect of treatment (F=0 
p=0.98). In the OFT (center) and EPM (right), there was a main effect of treatment (OFT: F=8.65 
p=0.003; EPM: F=7.37 p=0.007), with no post-hoc effect. Bars represent SEM. Data from 32 
sham animals, including outliers. Data is normalized to each individual animal’s baseline. 
 To determine if animals in these two clusters corresponded to distinct responses to TBI, 
we plotted for each assay, the values of anxiety metrics of animals in the two clusters (Fig.4.2B). 
We find that animals in the red cluster showed a significant difference with respect to animals 
from the blue cluster  (Fig. 4.2B; repeated thee-way ANOVA, EZM: main effect: F=19.89, p=0; 
OFT: main effect: F=10.06 p=0; EPM: main effect: F=120.07, p=0). Animals in the blue cluster 
showed minimal change in anxiety metrics over time  with respect to sham animals (Fig. 4.2B; 
post-hoc t-test with FDR correction, p>0.05). These results reveal that the two groups exhibit 
consistently distinct behavioral patterns across anxiety metrics and time following injury. 
Moreover, they demonstrate that animals in the blue cluster were largely ‘resilient’ to TBI (not 
different from sham), whereas animals in the red cluster were ‘vulnerable’ to injury (different 
from resilient and sham). We refer to this approach of identifying distinct behavioral groups from 
multidimensional profiles as multidimensional behavioral clustering with validation (MBCV). In 
this cohort, we found that only 3/37 animals were identified as vulnerable. 
 To increase the size of the vulnerable sample (for subsequent analyses), we repeated the 
experiment on a different cohort of 34 TBI animals (and 17 sham animals), and applied our 
MBCV analysis approach to this dataset (Fig. 4.2A; right panel). Because the two cohorts were 
separated by a 1.5 year window, we applied PCA and clustering independently to data from this 
second cohort. We identified 6 vulnerable and 28 resilient subjects in this cohort (behavior data 
for this cohort is shown on Sup. Figure 4.1B).  
 For all subsequent analyses, we merged the vulnerable (as well as resilient) groups from 
the two cohorts. First, we compare the proportion of time spent by animals vulnerable to TBI, 
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animals resilient to TBI as well as sham animals in the anxiogenic zone in each of the behavioral 
assays (Fig. 4.2C). We find systematic differences between the vulnerable and both resilient and 
sham animals, but no differences between the resilient and sham animals (Fig. 4.2C; EZM: 
repeated three-way ANOVA, main effect of treatment, F=95, p=0, post-hoc: vulnerable versus 
resilient and vulnerable versus sham, p<0.01 in all time-points. OFT: repeated three-way 
ANOVA, main effect of treatment, F=8.37, p=0.0003, post-hoc: vulnerable versus resilient and 
vulnerable versus sham p<0.05 on week one. EPM: repeated three-way ANOVA: main effect of 
treatment, F=12.45, p=0, effect of time, F=4.05, p=0.007, post-hoc, vulnerable versus resilient, 
p<0.05 in all time-points, vulnerable versus sham, p<0.05 on weeks three, five and seven).   
 Specifically, vulnerable animals spent a significantly higher proportion of time exploring 
the open arms in both the EPM and the EZM, and a trend towards greater exploration of the 
center in the OFT, as compared to the resilient animals (Fig. 4.2C). By contrast, in the EZM and 
EPM, resilient and sham animals showed no changes from baseline in the proportion of time 
spent in the anxiogenic zone (post-hoc t-test with FDR correction, p>0.05).  
 To further validate our approach, we investigated whether vulnerable versus resilient 
animals exhibited consistent results with respect to a different anxiety metric, one that was not 
used in the MBCV analysis to identify the groups. To this end, we compare a secondary anxiety 
metric between these groups of animals, namely, the number of entrances to the open arm for the 
EZM and the EPM (Fig. 4.2D), and find similar results to those from proportion of time spent in 
the anxiety zone. In the EZM we show that vulnerable animals present a greater number of 
entrances into the open arm than resilient and sham animals (Fig. 4.2D, left: repeated three-way 
ANOVA, F=3.92, p=0.02), with significant differences observed between vulnerable and resilient 
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Figure 4.4: Vulnerable animals present downregulation of GAD and vGLUT, and 
upregulation of NPY immunostaining in the mPFC. A) Top: schematics of brain sectioning 
showing where mPFC images were taken. Bottom: example of GAD65/67, vGLUT and NPY 
staining for resilient, vulnerable and sham animals B) Eta-squared effect size in the mPFC. 
comparing vulnerable animals to resilient and shams, and resilient animals to shams. Colors 
indicate strength of effect for metrics that presented a statistically significant difference (post-
hoc: p<0.05). C) Pixel and puncta analysis in the mPFC, for GAD65/67, vGLUT and NPY. 
Bars represent SEM. Data from 53 animals (vulnerable=9, resilient=28, sham=16), including 
outliers. *: p<0.05 and **: p<0.01, for difference between groups by post-hoc t-test with false 
discovery rate (FDR) correction.  
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Figure 4.5: Vulnerable animals present significant differences compared to resilient and 
sham animals in the BLA and vHPC. A) Schematics of brain sectioning showing where BLA 
and vHPC images were taken. B-C) Eta-squared effect size in the BLA (B) and vHPC (C), 
comparing vulnerable animals to resilient and shams, and resilient animals to shams. Colors 
indicate strength of effect for metrics that presented a significant statistical difference. Data from 
53 animals (vulnerable=9, resilient=28, sham=16), including outliers. 
animals on weeks three, five and seven (p<0.05, post-hoc t-tests with FDR correction), and 
significant differences between vulnerable and sham animals on weeks five and seven (p<0.05, 
post-hoc t-tests with FDR correction). In the EPM, there is no significant difference between 
groups (repeated three-way ANOVA, F=1.68, p=0.18), but there was a trend indicating that 
vulnerable animals presented more entrances into the open arm compared to resilient and control 
animals. Thus, findings based on our MBCV approach generalize, and are robust to the anxiety 
metric used. 
 We next assessed potential deficits in general locomotion by measuring the total distance 
travelled by mice in each of the three assays (Sup. Fig 4.1C). There is no difference in 
locomotion (normalized to baseline) between groups in the EZM (repeated three-way ANOVA, 
F=0.17, p=0.85,). In the EPM, there was a main effect of injury (repeated three-way ANOVA, 
F(2)=3.84, p=0.02,), but no significant post-hoc effect. In the OFT, there was a main effect of 
injury (repeated three-way ANOVA, F=29.74, p=0,) with vulnerable (but not resilient) animals 
being significantly more active than sham controls on weeks one, three, five and seven (p<0.05, 
post-hoc t-tests with FDR correction). These results are in agreement with previous findings that 
suggest increased overall locomotor activity following injury in the open field test. Notably, 
however, locomotion is not a confounding factor for the observed differences in anxiety-like 
behavior, between the vulnerable and resilient groups, in the EZM or the EPM. 
 We wondered whether the resilient vs. vulnerable  grouping was already evident in 
baseline measurements. We compared the anxiety metrics prior to injury for animals from these 
groups, and found no systematic differences in any of the anxiety tests (Fig. 4.2E). The 
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vulnerable group does not show differences from either the resilient or sham groups for either the 
EPM or the OFT (three-way ANOVA; OFT: F=1.01, p=0.36,; EPM: F=1.81, p=0.16,). 
Interestingly, in the EZM, vulnerable animals spent less time in the open arm during baseline, 
compared to the resilient and sham animals (Fig 4.2E-left, EZM: F=4.97, p=0.008). These results 
show that the enhanced exploratory behavior in the vulnerable group, compared to the resilient 
(and sham) group, arises subsequent to the injury.  
 We also wondered whether differences in injury severity between groups might account 
for their anxiety phenotypes. To this end, for each animal, we assessed the volume of the injured 
hemisphere (ipsi) relative to the volume of the uninjured hemisphere (contra) and compared 
across groups (Fig. 4.2F). We find a reduction in the normalized (ipsi/contra) hemispheric 
volume in the peri-injury area in both the TBI groups (vulnerable and resilient), compared to 
sham controls (three-way ANOVA, F=39.63, p<0.001, effect of treatment; p<0.001, post-hoc t-
test with FDR correction, vulnerable and resilient vs. sham). However, there was no difference 
between vulnerable and resilient animals (t-test, p=0.67). Additionally, there was no effect of the 
contralateral peri-injury hemispheric volume in TBI animals compared to sham controls 
(Supplementary Table 4, three-way ANOVA, F=1.52, p=0.23).  
 Our approach to identify distinct sub-groups within TBI animals was motivated by the 
hypothesis that the distributions of behavioral measures following injury versus sham surgery 
may overlap significantly, thereby making it difficult to isolate reliable differences in behavioral 
outcomes (and neural mechanisms) by the standard approach of comparing between these 
groups. To test if this underlying hypothesis was true, we plotted the distributions of behavioral 
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metrics in the TBI and sham groups. We found that this is, in fact, true: the distributions of 
anxiety behavioral metrics in the TBI and sham control groups exhibit substantial overlap (Sup. 
Fig. 4.1A). 
 Taken together, the above results establish the MBCV as a reliable approach for 
identifying two groups of animals, vulnerable and resilient, with distinct anxiety-like behavioral 
outcomes following injury.  
2.2 Application of MBCV approach to sham animals does not yield behaviorally distinct sub-
groups. 
 The success of MBCV approach applied to the TBI cohorts raises the question as to 
whether this approach is effective specifically for the TBI cohorts, or whether the fundamental 
idea of identifying two groups, applied to any distribution (batch of animals) can yield groups 
with distinct behavioral (specifically, anxiety) signatures due to intrinsic variability within 
distributions. Since each cohort also had, associated with it, a sham surgery group where the 
same behavioral measures were collected, we decided to test this question specifically on the 
sham animals. We applied PCA and clustering to each sham cohort, independently (Fig 4.3A). 
We then examined the individual behavioral metrics for the two clusters in each cohort, and 
found no systematic differences (Sup. Fig. 4.3). For improved statistical power for this 
comparison, we combined clusters across cohorts in both possible ways and found no systematic 
differences between the resulting groups, for either case (Fig. 4.3B: EZM, F=0.95 p=0.33; EPM, 
F=1.14 p=0.28; Fig. 4.3C: EZM, p=0.33, F(2)=0.95; OFT, p=0.003, F=8.65, orange animals 
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show higher values than pink animals; EPM, p=0.007, F=7.37, orange animals show lower 
values than pink animals, no post hoc effect). In other words, MBCV applied to sham animals 
did not produce groups that exhibited distinct patterns of behavioral outcomes that were 
consistent across anxiety metrics. 
2.3 Differences in mPFC molecular markers between vulnerable and resilient groups  
 Having identified vulnerable versus resilient groups based on their anxiety behavioral 
profiles, we next asked if there were systematic molecular differences that could serve as neural 
signatures of vulnerability and resilience. To assess molecular differences, we perfused the brains 
of the animals and performed immunohistochemistry. Specifically, we measured expression of 
three markers - an inhibitory marker (GAD65/67), an excitatory marker (vGLUT), and 
neuropeptide Y (NPY), in the mPFC, a key brain region involved in the control of anxiety [232]. 
Figures 4.4A and 4.5A show the location of imaging and sample images for all three markers in 
all animal groups (resilient, vulnerable and sham).  
 Staining for GAD in the mPFC showed a downregulation in both resilient and vulnerable 
animals compared to sham controls. There was a significant decrease in the average size of GAD 
65/67 puncta in the ipsilateral  as well as contralateral sides (Fig 4.4B- left column, third row;  
ANOVA, F=4.07, p=0.02; contra: ANOVA, F=6.54, p=0.003; post-hoc t-test with FDR 
correction, p<0.05 for both sides of the brain). However, there were no differences in GAD 
staining between vulnerable and resilient animals.  
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Figure 4.6: molecular changes in vulnerable animals correlate with behavioral outcomes in the 
EZM on week seven. A) Correlation values between molecular metrics and behavioral results for 
vulnerable animals in the EZM on week seven. Colors indicate strength of correlation, whenever there 
was a significant main effect in the molecular metric. B) Correlation plots showing strong correlations 
between molecular metric and behavior. Data from 9 vulnerable animals, no outliers were removed.
 Staining for vGLUT in the mPFC showed a downregulation specifically in vulnerable 
animals compared to sham controls. The total intensity of vGLUT pixels was marginally lower, 
and number of their puncta and the average puncta size were significantly lower on the ipsilateral 
side in vulnerable animals (Fig. 4.4B-middle column, top three rows; pixel intensity:  ANOVA, 
F=2.31, p=0.1; puncta number: ANOVA, F=3.35, p=0.04, post-hoc t-test with FDR correction 
p<0.05; puncta size: ANOVA: F=3.44, p=0.04, post-hoc t-test with FDR correction, p<0.05). The 
average puncta size was lower on the contralateral side as well for vulnerable animals in 
comparison to sham controls (Fig. 4.4B - middle column, third row; ANOVA: F=3.4, p=0.04, 
post-hoc t-test with FDR correction, p<0.05). Notably, in all cases, there were no differences 
between the resilient animals and sham controls.  
 Staining for NPY, a marker for resilience to stress [181, 240], on the other hand, showed 
an upregulation in the mPFC, and specifically in vulnerable animals. The average puncta size 
and intensity were significantly higher on the contralateral side in vulnerable animals (Fig. 4.4B - 
right column, bottom two rows; size: ANOVA, F=8.99, p=0.0007; intensity: F=3.53, p=0.03). 
Notably, in both cases, vulnerable animals were different from both control and resilient animals 
for the average puncta size (post-hoc t-test with FDR correction, p<0.05), and there were no 
differences between resilient and sham animals.  
 To visualize these effects succinctly, we plotted a matrix of effect sizes observed in the 
comparisons between all pairs of groups (vulnerable vs resilient, vulnerable vs sham, and 
resilient vs sham) for each of these molecular measures (Fig. 4.4C); the size of the effect was 
coded by color. This matrix indicates clearly that the resilient group does not show strong 
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changes with respect to control (η2>0.06) in any of the metrics measured. By contrast, the 
vulnerable group shows a strong effect size (η2>0.06) with respect to sham control in some 
metrics, such as puncta size of GAD 65/67 staining, puncta size, number and total pixel intensity 
of vGLUT immunostaining, and puncta size for NPY immunostaining (GAD: vulnerable vs 
sham, puncta size, contra: η2=0.22, p=0.01; resilient vs sham, puncta size, contra: η2=0.22, 
p=0.01; vGLUT: vulnerable vs sham, puncta size, ipsi: η2=0.3, p=0.003, contra η2=0.29, 
p=0.004; number of puncta, ipsi: η2=0.27, p=0.006; total px intensity, ipsi: η2=0.24, p=0.01; 
NPY: vulnerable vs sham, puncta size, contra: η2=0.37, p=0.008). Interestingly, there is a 
moderate or strong effect on vGLUT immunostaining when comparing vulnerable and resilient 
groups (vGLUT: vulnerable vs resilient, puncta size, ipsi: η2=0.33, p=0.001, contra: η2=0.16, 
p=0.02). 
2.4 Differences between vulnerable and resilient groups in molecular markers in the vHPC and 
BLA 
 Additionally, in these same animals, we also measured expression of GAD65/67, vGLUT 
and NPY in two other nuclei important to the control of anxiety, namely the basolateral amygdala 
(BLA) and ventral hippocampus (vHPC) [218, 231]. Figure 4.5A shows the location of imaging 
in each of these brain regions. 
 In the BLA (Sup. Fig. 4.5B), we found that only a few metrics showed an effect of the 
animal group (vulnerable, resilient or sham). Specifically, we found that vulnerable animals, 
when compared to resilient (and sham) animals showed a moderate reduction in the total number 
of GAD 65/67 puncta in the ipsilateral side (Sup. Fig. 4.5B, Fig. 4.5B, GAD column,  ANOVA: 
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F=3.91, p=0.02; post-hoc t-test with FDR correction, p<0.05), and a moderate decrease in the 
size of GAD puncta in the contralateral side (Sup. Fig. 4.5A; Fig. 4.5B, GAD column; ANOVA: 
F=4.37, p=0.01, post-hoc t-test with FDR correction, p<0.05). For VGLUT staining, vulnerable 
animals showed a significant reduction in the total # VGLUT puncta compared to sham controls 
on the contralateral side (Sup. Fig. 4.5B;Fig. 4.5B, VGLUT column; ANOVA: F=2.24, p=0.02, 
post-hoc t-test with FDR correction, p<0.05), suggesting a downregulation of VGLUT. However, 
we found no significant differences specifically between vulnerable and resilient animals on any 
of the VGLUT metrics (Fig. 4.5A; Fig. 5B, VGLUT column). For NPY staining, vulnerable 
animals showed a strong increase in the size of NPY puncta compared to resilient (as well as 
control) animals on the contralateral side (Sup. Fig. 4.5A; Fig. 4.5B, NPY column; ANOVA: 
F=8.78, p=0.001, post-hoc t-test with FDR correction, p<0.05). Across all markers, there were no 
differences in the BLA between resilient animals and sham controls on any of the metrics. 
 In the vHPC (Sup. Fig. 4.5B) as well, we found that there were only a few metrics (across 
all the markers) that showed an effect of the animal group. Specifically, we found that vulnerable 
animals, when compared to resilient animals, showed a significant reduction in the intensity of 
GAD puncta (ipsilateral side; Fig. 4.5C-GAD column; ANOVA: F=3.88 p=0.03, post-hoc t-test 
with FDR correction, p<0.05) and a marginally significant increase in the intensity of NPY 
puncta (ipsilateral side; Fig. 4.5C-NPY column; ANOVA: F=2.67, p=0.08, post-hoc t-test with 
FDR correction, p<0.05). Additionally, vulnerable animals, when compared to sham controls, 
also showed a reduction in GAD staining (Fig. 4.5C-GAD column; ipsilateral puncta intensity: 
post-hoc t-test with FDR correction, p<0.05), and a reduction in VGLUT staining e (Fig. 4.5C-
VGLUT column; contralateral total intensity: ANOVA: F=3.13, p=0.05, contralateral total # 
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puncta: ANOVA: F=3.36, p=0.04, post-hoc t-test with FDR correction, p<0.05).  Across all 
markers, there were no differences in the vHPC between resilient animals and sham controls on 
any of the metrics. 
 In sum, in the BLA, when comparing the vulnerable versus resilient groups, there was a 
moderate downregulation of GAD staining and a strong upregulation of NPY staining, but no 
effects of VGLUT staining. In the vHPC, there was a weak downregulation of GAD, a moderate 
upregulation of NPY, and no effects of VGLUT.  
 Together with the results from mPFC, our findings reveal that vulnerability to anxiety 
outcomes following injury are associated with distinct molecular profiles as compared to resilient 
injured animals, with stronger overall effects in the mPFC than vHPC or BLA: decreases in 
metrics of vGLUT and GAD 65/67 staining in mPFC, decreases in metrics of GAD65/67 
staining in BLA and vHPC, as well as increases in NPY staining in all three areas. These 
molecular metrics (total of 17) that specifically exhibit a difference in vulnerable versus resilient 
and control animals are referred to as molecular indicators of vulnerability. 
2.5 Relationship between behavioral and molecular metrics among vulnerable individuals. 
 The finding of distinct molecular signatures for vulnerability to injury versus resilience 
motivated us to ask whether, at an individual level, the molecular profiles of the injured animals 
varied systematically with the extent of vulnerability to anxiety outcomes, across animals. To this 
end, we identified a key behavioral metric, out of the 11 metrics that constitute an animal’s 
behavioral profile (EZM week 7), and examined its correlation (across animals) with each of the 
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17 molecular indicators of vulnerability identified in Figures 4.4 and 4.5. Examination of the 
relationship between this behavioral variable and each of the molecular indicators revealed that 
most (8/17) showed significant positive correlation across animals (Supplementary Tables 1-3). 
We then generated a color-coded matrix summarizing the extent of correlation of the various 
molecular indicators with the behavioral metric (Fig 4.6A). We found that there was a strong 
correlation between decreases in vGLUT immunostaining in the mPFC (total intensity, puncta 
number and size), and in the BLA (total intensity), with individual vulnerability. Similarly, there 
was a strong or moderate correlation between decreases in GAD 65/67 observed in the mPFC 
(puncta size), in the BLA (puncta size and number), and in the vHPC (puncta intensity), with 
individual vulnerability. Figure 4.6B illustrates the subsets of metrics and regions where strong 
correlations between molecular and behavioral measures were observed. 
 To test if this strong positive correlation was unique to vulnerable animals, of whether the 
intrinsic variability of metric values within any population of animals would show such a 
correlation, we repeated this analysis for resilient animals as well as sham controls (Fig. 4.6B, 
blue and grey dots, respectively). We found that there were no significant correlations between 
the molecular indicators and behavioral metric for animals in these two groups (Sup. Tables 1-3).  
3. Conclusion 
 In this study, we hypothesized that TBI would lead to a range of anxiety outcomes in an 
animal model of injury, and that these outcomes would correlate with different molecular 
signatures. This hypothesis is based on the knowledge that, in clinical TBI, not all patients are 
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equally affected in terms of neuropsychiatric outcomes, and only about a third will develop 
anxiety disorders [6]. 
 To test this hypothesis, we combined a dimensionality reduction method, namely,  PCA,  
and a clustering technique, k-means, and we found that TBI animals present two behavioral 
profiles. Resilient animals did not change their anxiety level in reference to their baseline, and 
they presented a similar behavior to control animals. Vulnerable animals, on the other hand, 
significantly increased the exploration of the anxiogenic zone in the behavioral mazes in a 
consistent manner, indicating a deficit in risk-assessment, or an increase in risk-taking behavior. 
This change is consistent what has been reported in the literature, that TBI patients, in particular 
those who suffer moderate to severe brain injury,  also present increased impulsivity and 
compulsive behaviors [241, 242]. 
 We were also interested in exploring molecular markers in anxiety-associated regions of 
the brain, that may indicate distinctions with resilience and vulnerability. We found neural 
signatures, in particular in the mPFC of vulnerable animals, indicating that vulnerability could be 
associated with molecular changes: specifically, downregulation of vGLUT and GAD65/67, and 
upregulagion of NPY. We found a strong correlation between the extent of behavioral 
vulnerability, as measured by their performance in the EZM at week 7,  and  the extent of 
changes in these molecular metrics for the vulnerable animals. Our results demonstrate that the 
approach of separating TBI animals based on their behavioral profile is promising and can shed 
light in anxiety outcomes of TBI in animal models. 
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Chapter 5: Discussion and future directions 
 Anxiety outcomes following traumatic brain injury are complex and variable. Whereas 
suffering from TBI does not always lead to anxiety, the prevalence of this type of disorder is 
higher among TBI patients than the general population [7]. Thus, animal models of TBI and 
anxiety offer a valuable opportunity to understand the neural mechanisms of injury that lead to 
these outcomes and help to develop better clinical treatments. However, the field suffers from a 
lack of consensus regarding the effects of TBI on anxiety-like behaviors, which complicates the 
interpretation of the underlying mechanisms of injury that lead to anxiety post-injury. We 
hypothesized that the inconsistencies are due to factors such as differences (across studies) in 
injury models and severity, in behavioral assays and metrics, in time-points adopted, and perhaps 
most importantly, individual differences in brain’s response to the injury. 
 We carried out a series of studies to directly address some of these issues. In chapter 
three, we adopted a battery of behavioral assays for anxiety and tested animals at several time 
points over seven weeks. By comparing behavioral patterns across assays and repeatedly testing 
animals over a long time-course, we were able to identify patterns in how anxiety changed over 
time and across assays. We also normalized all our behavioral data to each animals’ baseline to 
test the effect of the injury in comparison to individual animals’ baseline levels of anxiety. our 
results pointed to time and task dependence on the effects of TBI in anxiety. We observed an 
early increase anxiety-like behavior (measured in the EPM and EZM), followed by a late 
decrease (measured in the EZM and OFT), in mice exposed to CCI. Changes in GABA signaling 
accompanied these behavioral results, and specifically, TBI animals presented an increased 
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number and intensity of GAD pixels, as well as an increased number of puncta, suggesting 
enhanced inhibition in the BLA, associated with the late decrease in anxiety. This study indicated 
that the effects of TBI, compared to the effects of sham surgery, are not uniform over time nor 
across multiple behavioral assays. These results suggested that the use of subsets of assays or 
fixed time points could be a potential explanation for the conflicting results in anxiety outcomes 
following TBI reported in the literature.  
1. Individual vulnerability 
 We next wondered if there may be a deeper issue at play, especially since TBI is a 
complex pathology, and even in highly reproducible models, animals can present varying 
outcomes. Could the variability in each individual’s response to injury be an important factor 
underlying the conflicting and widely variable results in the literature? In chapter four, we 
directly addressed this issue of variability within TBI animals. Our primary hypothesis was that 
the injury would affect animals in different ways, with some exhibiting behavioral changes 
similar to those observed in sham animals, and other showing aberrant behavior. If true, this 
would imply that comparing a group of TBI animals with highly variable behavioral outcomes, 
to a group of sham animals with outcomes that overlap substantially may be a flawed approach. 
An important factor that exacerbates this issue is the standard statistical practice of outlier 
removal. For a distribution that is highly variable, the removal of ‘outliers’ can eliminate 
precisely those individual points that may be the most informative.   
To test this hypothesis, we first compared the distributions of anxiety outcomes following 
TBI versus sham surgery and found substantial overlap between them, as hypothesized. Next, we 
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developed a quantitative approach that could be applied to our high dimensional behavioral 
dataset (assays x time-points) to identify distinct behavioral subgroups within the TBI animals. 
We reduced our high dimensional behavioral data into fewer dimensions that explained most of 
the variability, and then applied a clustering method to separate TBI animals into two 
behaviorally distinct groups. We identified that one group of TBI animals was resilient to anxiety 
changes following injury, since their behavior did not change compared to their pre-injury 
baseline (nor to sham controls), whereas the other group was vulnerable to anxiety changes 
following injury: they presented a marked increase in time spent in the dangerous zone of the 
behavioral tests. Notably, this behavioral vulnerability was associated with molecular signatures 
in key brain regions; specifically, vulnerable animals presented downregulation of vGLUT and 
GAD65/67 in the mPFC and BLA, and upregulation of NPY in the mPFC and BLA. These 
results confirmed our hypotheses that the effects of standardized injury are widely variable 
across individuals, and that vulnerability to anxiety following TBI has specific neural signatures. 
Additionally, they shed new light on anxiety outcomes of TBI in animal models: individual 
variability is a major factor in these outcomes, and accounting for it can yield rich insights into 
neural mechanisms underlying the outcomes.  
 We have demonstrated that resilience and vulnerability are fundamental to understanding 
the anxiety outcomes of TBI. The concept of psychological resilience is not new and has been 
extensively described in humans, in the context of resilience to psychosocial stress [243-245] and 
in animal models of stress, in which it has been demonstrated that stress does not affect all 
animals equally [175, 178, 182]. Resilience, in the context of stress, is defined broadly as the 
ability of an organism to adapt to adversity, by the engagement of coping strategies [226]. 
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Vulnerability to stress, on the other hand, is the lack of coping strategies and has been implicated 
in triggering or worsening several psychiatric disorders, such as schizophrenia [246], post-
traumatic stress disorder [247], depression [248] and anxiety [249].  Both animal and human 
literature have started to identify genetic, molecular, and developmental factors that make some 
organisms more vulnerable to neuropsychiatric disorders than others following exposure to a 
stressful event. Among the markers for resilience and vulnerability, a subunit of GABAb receptor 
has been identified as a marker for resilience to stress: knockout animals lacking this isoform 
were more prone to depression than their counterparts [250]. Resilience also depends on DNA 
methylation of the neuropeptide corticotrophin-releasing factor (CRF) gene, which is involved in 
the activation of the neuroendocrine stress response. Chronic stress causes demethylation of this 
genomic region and leads to a vulnerable phenotype in defeated animals [179]. Early life stress 
can also induce vulnerability by changing gene expression in the hippocampus and medial 
prefrontal cortex [251, 252]. Those markers show that resilience is a complex, multidimensional 
phenomenon, dependent on the interaction of both genetic and environmental factors.  
In this context, injury can be considered a ‘stressor’, both physically, due to the damage 
to the brain, and psychologically, for its emotional effects. It is appropriate, then, to consider how 
the exposure to the injury will lead to different levels of vulnerability and resilience. Clinical TBI 
studies do recognize that patients present different levels of vulnerability to developing anxiety 
as a sequela of injury. However, the role of resilience and vulnerability in the context of TBI has 
received little explicit attention, with only a few studies have measured patients’ resilience 
following injury [253-256] [257]. Even fewer studies have (in fact, just one has) applied the 
concept of resilience and vulnerability to outcomes of TBI in pre-clinical models. In a study of 
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the long-term cognitive effects of a bilateral frontal CCI, the authors found three distinct groups 
of animals: some who did not present any level of cognitive deficit (TBI-resilient), a portion who 
only recovered the full cognitive function after 14 weeks (TBI-vulnerable), and some who never 
recovered they cognitive function (chronically-impaired) [258]. Although they divided animals 
in terms of their adaptation to the injury, they did not compare neural markers among these 
behaviorally distinct groups. This study shows that even for cognitive outcomes, animals will 
present different degrees of resilience to the harmful effects of the injury. In another study, 
researchers discussed that the variability in behavioral outcomes following a closed head weight-
drop injury in juvenile rats may be due to innate resilience or vulnerability among animals. 
However, they do not explore this idea in their analysis, i.e., they did not separate the animals 
into vulnerable and resilient to measure differences between these groups [259]. Additionally, 
some researchers found that special diets rich in zinc and glucose reduce anxiety- and 
depressive-like symptoms following TBI [204, 260]. Whereas they refer to the results as 
resilience, they are better described as improved outcomes due to a specific intervention or 
therapy, rather than an intrinsic, protective mechanism that affords animals the ability to adapt to 
the injury and exhibit less severe sequelae. To the best of our knowledge, no previous study has 
applied the concept of resilience and vulnerability to anxiety outcomes of TBI in animal models.  
2. Increased exploration of exposed spaces: adaptive or dysfunctional?  
 Here, our use of the vulnerability vs. resilience approach revealed that vulnerable animals 
presented an increased exploration of the exposed (high anxiety) zones within various behavioral 
arenas following TBI. A challenge in interpreting these behavioral results is that it requires 
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inferring the animals’ emotional state while exploring the mazes. In the specific case of anxiety-
like behaviors in rodents, the inference is often ethologically-based: in their natural environment, 
rodents will engage in two opposing, competing behaviors: exploring a new area and seeking 
protection [261]. The default interpretation is that when animals spend more time in an exposed 
zone, they are displaying low anxiety, whereas increased time in the enclosed area indicates high 
anxiety [262]. This relies on approximating the animal’s emotional state in these contexts based 
on the level of avoidance: high avoidance is taken to signal high anxiety, while low avoidance is 
taken to signal low anxiety [170]. Consistent with the fact that avoidance of potential threat is a 
fundamental aspect of human anxiety [263], increased exploration of the exposed zone, i.e., a 
reduction in anxiety, is often interpreted as an adaptive response, while decreased exploration, 
i.e., an increase in anxiety, is interpreted as a maladaptive response (‘anxiety disorder’). 
However, engaging in an excessive exploration of a dangerous area can expose animals to 
unnecessary threats [264], demonstrating lack of behavioral control, and therefore, can itself be 
maladaptive. In other words, exploration and avoidance are balanced behaviors [265], and a 
tilting of the balance either towards excessively protective behavior, or towards excessively risky 
behavior are both plausibly interpreted as dysfunctional behavioral states. Consistent with this 
view, in clinical studies, reports of patients engaging in risky behaviors following TBI are not 
uncommon. Addiction, careless and violent behavior, and suicide have been reported following 
injury [120, 266-268]. 
Based on these ideas, we concluded that the increased exploration of the exposed zones that we 
observed in vulnerable animals following injury, is not adaptive, but rather represents a 
dysfunctional, maladaptive anxiety state. Understanding the mechanisms underlying such 
94
dysfunction after the injury can potentially inform the development of treatments for patients 
engaging in risk-prone behavior post-injury.  
3. Caveats and open issues 
 In this work, we adopted one focal TBI model, which caused a moderate to severe injury, 
and in which only about 13% of animals were vulnerable. It would be relevant to test if different 
injury models and severities alter the level of vulnerability and resilience among animals. Are 
there specific injury types that increase the chance of animals developing the vulnerable 
phenotype? Are the neural mechanisms similar or distinct?  
 Additionally, we only tested male animals. Women often suffer from anxiety-related 
disorders more often than men [269-271], and although men are twice as likely to suffer a TBI 
than women [272], women are more likely to suffer from anxiety post-injury [273]. This raises 
the question of whether women are more vulnerable to suffering from anxiety disorders post-
TBI, and whether the mechanism of injury that causes vulnerability is the same in both sexes.  
 Finally, anxiety dysfunction is only one among the range of affective disorders that 
commonly affect TBI patients. For example, the prevalence of depression post-TBI is also high 
[274], and comorbidity between anxiety and depression is not unusual [275]. Our approach of 
combining different behavioral metrics from TBI animals to identify distinct behavioral groups 
based on their levels of resilience to the injury, and then investigating associated neural 
mechanisms, is versatile. The ability of this approach to operate on a multidimensional 
behavioral dataset, regardless of the number and identity of behavioral assays used or the number 
of timepoints tested, and still identify relevant behavioral differences among animals, allows for 
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general applicability. Therefore, this approach can be used readily by researchers to test if other 





Supplementary Table 1: Correlation values (rho) and p-values for comparisons between EZM 
week seven and vGLUT plots that presented a statistically significant difference between 
vulnerable, resilient and sham animals. Asterisk indicates p<0.05. 
Supplementary Table 2: Correlation values (rho) and p-values for comparisons between EZM 
week seven and GAD plots that presented a statistically significant difference between 
vulnerable, resilient and sham animals. Asterisk indicates p<0.05.  
Supplementary Table 3: Correlation values (rho) and p-values for comparisons between EZM 
week seven and NPY plots that presented a statistically significant difference between 
vulnerable, resilient and sham animals. Asterisk indicates p<0.05.  
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Supplementary Table 4: contralateral and ipsilateral volume in sham controls, resilient and 
vulnerable animals. A three-way ANOVA shows no main effect of treatment in the contralateral 
side (F=1.52, p=0.23), and a main effect of treatment in the contralateral side (F=4.42, p=0.019), 
and TBI animals (resilient and vulnerable) presented a significant decrease in ipsilateral 
hemispheric volume compared to sham controls (p<0.05). Resilient and vulnerable animals did 
not differ from each other.  
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Supplementary Figure 4.2: A) Histogram showing the proportion of time in the EZM across all 
time-points (x-axis) and the frequency of occurrences (y-axis), separating animals into sham, 
resilient and vulnerable. B) Proportion of time resilient and vulnerable animals from cohort B 
spent in the anxiogenic zones in the EZM, OFT and EPM. There was a main effect of treatment in 
the EZM (F=56.34, p>0.001), and a post-hoc effect on weeks one, three, five and seven. There 
was a marginal main effect of treamtne in the OFT (F=2.08, p=0.1), with no post-hoc effect. 
There was no main effect of treatment in the EPM (F=1.43, p=0.24). C) Total distance travelled in 
the mazes, combining cohort A and B. There was a main effect of treatment in the OFT (center, 
F=29.74, p=0,) with vulnerable animals traveling more than sham animals on weeks one, three 
and five (p<0.05), and in the EPM (F=3.84, p=0.02), with no post-hoc effect.
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Supplementary Figure 4.3: proportion of time in anxiogenic zone for sham controls, 
separated by cohort A and cohort B. In the EZM, there was a main effect of treatment for 
Cohort A (A, F=40.48, p<0.0001) and cohort B (D, F=4.36, p=0.004), with a post-hoc effect on 
weeks one and three for cohort A. In the OFT, there was no main effect of treatment for neither 
cohort A (B, F=0.58, p=0.44) or cohort B (E, F=0.003, p=0.85). In the EPM, there was no main 
effect of treatment for cohort A (C, F=2.87, p=0.09), and there was a main effect of treatment 
for cohort B (F, F=60.63 p<0.001), with a post-hoc effect on week three.
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Supplementary Figure 4.4: Pixel and puncta analysis in the BLA (A) and vHPC (B), for GAD65/67, 
vGLUT and NPY. Bars represent SEM. Data from 53 animals (vulnerable=9, resilient=28, sham=16), 
including outliers. *: p<0.05 and **: p<0.01, for difference between groups by post-hoc t-test with false 
discovery rate (FDR) correction. 
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